Provinces;Age ranges;Cohorts;Sex;Demographic Concepts;Period;Total
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,152,930
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;3,004,925
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;2,911,594
National Total;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.31
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.35
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,963,343
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;1,875,050
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;1,822,502
National Total;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.50
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.83
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,189,587
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;1,129,875
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;1,089,092
National Total;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.98
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.55
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,156,533
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;3,050,767
National Total;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
National Total;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.65
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,963,778
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;1,903,731
National Total;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
National Total;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.94
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,192,755
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;1,147,036
National Total;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
National Total;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.17
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
National Total;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
National Total;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;222,515
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;202,371
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;190,341
National Total;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90.95
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85.54
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;137,664
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;125,471
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;118,387
National Total;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.14
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86.00
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;84,851
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;76,900
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;71,954
National Total;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90.63
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84.80
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;200,747
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;187,336
National Total;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
National Total;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.32
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;125,663
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;117,588
National Total;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
National Total;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.57
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;75,084
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;69,748
National Total;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
National Total;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.89
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;540,771
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;509,654
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;490,132
National Total;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.25
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.64
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;315,885
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;298,299
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;287,751
National Total;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.43
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.09
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;224,886
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;211,355
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;202,381
National Total;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.98
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.99
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;520,045
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;498,140
National Total;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
National Total;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.79
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;303,305
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;291,328
National Total;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
National Total;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.05
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;216,740
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;206,812
National Total;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
National Total;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.42
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;899,258
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;863,754
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;840,077
National Total;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.05
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.42
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;554,627
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;533,823
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;521,121
National Total;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.25
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.96
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;344,631
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;329,931
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;318,956
National Total;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.73
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.55
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;868,633
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;842,217
National Total;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
National Total;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.96
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;532,141
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;517,819
National Total;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
National Total;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.31
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;336,492
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;324,398
National Total;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
National Total;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.41
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;949,089
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;919,584
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;899,959
National Total;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.89
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.82
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;602,960
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;585,559
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;574,762
National Total;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.11
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.32
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;346,129
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;334,025
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;325,197
National Total;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.50
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.95
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;965,647
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;943,304
National Total;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
National Total;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.69
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;612,352
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;599,980
National Total;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
National Total;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.98
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;353,295
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;343,324
National Total;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
National Total;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.18
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;541,297
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;509,562
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;491,085
National Total;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.14
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.72
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;352,207
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;331,898
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;320,481
National Total;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.23
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.99
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;189,090
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;177,664
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;170,604
National Total;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.96
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.22
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;601,461
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;579,770
National Total;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
National Total;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.39
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;390,317
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;377,016
National Total;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
National Total;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.59
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;211,144
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;202,754
National Total;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
National Total;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.03
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
National Total;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;25,147
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;24,144
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;23,354
02 Albacete;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.01
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.87
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;16,407
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;15,772
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;15,352
02 Albacete;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.13
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.57
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;8,740
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;8,372
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;8,002
02 Albacete;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.79
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.56
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;25,111
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;24,234
02 Albacete;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
02 Albacete;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.51
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;16,361
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;15,883
02 Albacete;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
02 Albacete;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.08
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;8,750
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;8,351
02 Albacete;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
02 Albacete;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.44
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,794
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1,652
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1,540
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92.08
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85.84
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,135
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1,041
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;986
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.72
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86.87
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;659
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;611
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;554
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.72
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84.07
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,616
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1,503
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
02 Albacete;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.01
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,018
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;959
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
02 Albacete;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.20
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;598
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;544
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
02 Albacete;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;90.97
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,160
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;3,971
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;3,814
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.46
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.68
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,538
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;2,435
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2,349
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.94
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.55
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,622
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1,536
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1,465
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.70
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.32
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,932
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;3,760
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
02 Albacete;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.63
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,405
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2,311
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
02 Albacete;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.09
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,527
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1,449
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
02 Albacete;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.89
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,900
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;6,672
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;6,498
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.70
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.17
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,467
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;4,322
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;4,231
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.75
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.72
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,433
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2,350
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2,267
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.59
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.18
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,665
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;6,477
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
02 Albacete;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.18
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,279
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;4,179
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
02 Albacete;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.66
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,386
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2,298
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
02 Albacete;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.31
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,797
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;7,595
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;7,419
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.41
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.15
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,189
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;5,057
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;4,973
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.46
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.84
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,608
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2,538
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2,446
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.32
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.79
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;7,807
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;7,613
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
02 Albacete;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.52
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,172
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;5,074
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
02 Albacete;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.11
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,635
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2,539
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
02 Albacete;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.36
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,496
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;4,254
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;4,083
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.62
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.81
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,078
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2,917
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2,813
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.77
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.39
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,418
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1,337
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,270
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.29
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.56
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;5,091
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;4,881
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
02 Albacete;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.88
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,487
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;3,360
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
02 Albacete;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.36
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,604
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1,521
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
02 Albacete;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.83
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
02 Albacete;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;145,490
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;138,171
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;133,559
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.97
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.80
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;90,963
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;86,656
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;84,069
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.27
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.42
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;54,527
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;51,515
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;49,490
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.48
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.76
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;146,800
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;141,474
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.37
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;91,761
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;88,713
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.68
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;55,039
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;52,761
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.86
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;9,995
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;9,119
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;8,575
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.24
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85.79
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,308
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;5,779
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;5,446
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.61
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86.33
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,687
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;3,340
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;3,129
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90.59
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84.87
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;9,116
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;8,494
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.18
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,852
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;5,453
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.18
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,264
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;3,041
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93.17
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;24,890
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;23,415
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;22,535
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.07
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.54
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;14,579
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;13,751
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;13,291
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.32
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.17
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;10,311
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;9,664
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;9,244
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.73
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.65
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;24,132
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;23,106
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.75
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;14,161
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;13,605
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.07
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;9,971
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;9,501
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.29
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;42,418
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;40,617
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;39,434
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.75
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.97
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;26,111
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;25,075
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;24,424
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.03
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.54
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;16,307
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;15,542
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;15,010
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.31
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.05
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;41,500
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;40,176
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.81
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;25,400
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;24,649
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.04
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;16,100
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;15,527
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.44
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;43,743
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;42,171
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;41,118
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.41
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.00
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;27,848
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;26,927
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;26,343
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.69
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.60
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;15,895
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;15,244
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;14,775
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.90
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.95
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;44,691
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;43,499
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.33
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;28,345
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;27,696
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.71
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;16,346
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;15,803
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.68
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;24,444
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;22,849
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;21,897
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.47
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.58
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;16,117
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;15,124
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;14,565
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.84
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.37
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;8,327
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;7,725
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;7,332
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.77
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88.05
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;27,361
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;26,199
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.75
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;18,003
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;17,310
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.15
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;9,358
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;8,889
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.99
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
03 Alicante/Alacant;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;42,797
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;40,828
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;39,549
04 Almería;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.40
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.41
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;26,219
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;25,071
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;24,360
04 Almería;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.62
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.91
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;16,578
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;15,757
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;15,189
04 Almería;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.05
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.62
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;42,953
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;41,511
04 Almería;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
04 Almería;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.64
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;26,303
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;25,493
04 Almería;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
04 Almería;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.92
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;16,650
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;16,018
04 Almería;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
04 Almería;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.20
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,320
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;3,061
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2,898
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92.20
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87.29
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,020
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1,871
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1,768
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92.62
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87.52
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,300
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,190
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,130
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91.54
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86.92
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,047
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2,851
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
04 Almería;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.57
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,890
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1,764
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
04 Almería;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.33
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,157
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,087
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
04 Almería;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93.95
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,690
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;7,270
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;7,004
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.54
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.08
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,450
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;4,227
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4,085
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.99
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.80
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,240
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3,043
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;2,919
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.92
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.09
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;7,397
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;7,110
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
04 Almería;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.12
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,294
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4,129
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
04 Almería;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.16
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,103
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;2,981
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
04 Almería;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.07
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;12,723
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;12,212
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;11,846
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.98
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.11
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,716
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;7,435
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;7,234
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.36
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.75
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,007
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;4,777
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;4,612
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.41
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.11
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;12,288
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;11,897
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
04 Almería;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.82
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;7,410
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;7,203
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
04 Almería;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.21
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,878
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;4,694
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
04 Almería;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.23
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;12,283
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;11,914
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;11,658
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.00
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.91
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,676
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;7,455
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;7,325
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.12
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.43
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,607
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;4,459
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;4,333
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.79
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.05
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;12,570
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;12,268
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
04 Almería;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.60
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;7,835
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;7,677
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
04 Almería;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.98
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,735
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;4,591
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
04 Almería;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.96
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,781
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;6,371
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;6,143
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.95
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.59
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,357
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;4,083
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3,948
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.71
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.61
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,424
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2,288
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2,195
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.39
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.55
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;7,651
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;7,385
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
04 Almería;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.52
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,874
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;4,720
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
04 Almería;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.84
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,777
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2,665
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
04 Almería;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.97
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
04 Almería;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;18,166
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;17,396
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;16,928
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.76
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.19
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;11,166
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;10,680
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;10,432
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.65
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.43
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;7,000
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;6,716
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;6,496
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.94
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.80
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;18,077
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;17,555
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.11
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;11,103
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;10,815
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.41
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;6,974
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;6,740
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.64
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,142
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1,050
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;994
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.94
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87.04
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;701
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;643
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;614
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.73
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87.59
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;441
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;407
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;380
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.29
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86.17
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,038
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;972
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.64
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;664
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;626
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.28
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;374
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;346
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.51
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,696
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2,549
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;2,452
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.55
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.95
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,539
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1,447
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1,401
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.02
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.03
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,157
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1,102
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1,051
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.25
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.84
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,610
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;2,503
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.90
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,479
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1,426
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.42
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,131
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1,077
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.23
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,981
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;4,831
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;4,721
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.99
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.78
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,009
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;2,911
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;2,853
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.74
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.82
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,972
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;1,920
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;1,868
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.36
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.73
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,749
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;4,624
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.37
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,833
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;2,765
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.60
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,916
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;1,859
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.03
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,021
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;5,849
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;5,757
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.14
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.62
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,759
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;3,656
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;3,609
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.26
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.01
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,262
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2,193
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2,148
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.95
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.96
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,053
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;5,956
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.40
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,759
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;3,710
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.70
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,294
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2,246
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.91
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,326
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;3,117
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;3,004
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.72
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.32
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,158
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2,023
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1,955
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.74
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.59
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,168
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1,094
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,049
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.66
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.81
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,627
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;3,500
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.50
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,368
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;2,288
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.62
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,259
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1,212
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.27
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
01 Araba/Álava;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;62,834
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;60,182
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;58,542
33 Asturias;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.78
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.17
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;36,994
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;35,465
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;34,627
33 Asturias;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.87
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.60
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;25,840
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;24,717
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;23,915
33 Asturias;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.65
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.55
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;62,715
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;60,868
33 Asturias;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
33 Asturias;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.05
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;36,836
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;35,872
33 Asturias;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
33 Asturias;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.38
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;25,879
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;24,996
33 Asturias;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
33 Asturias;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.59
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,270
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;2,977
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2,799
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.04
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85.60
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,931
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1,768
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1,672
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.56
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86.59
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,339
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,209
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,127
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90.29
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84.17
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,941
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2,736
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
33 Asturias;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.03
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,771
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1,659
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
33 Asturias;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.68
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,170
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,077
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
33 Asturias;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.05
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;9,256
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;8,799
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;8,506
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.06
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.90
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,086
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;4,845
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4,705
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.26
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.51
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,170
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3,954
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;3,801
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.82
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.15
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;8,743
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;8,405
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
33 Asturias;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.13
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,748
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4,575
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
33 Asturias;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.36
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,995
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;3,830
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
33 Asturias;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.87
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;18,194
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;17,571
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;17,174
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.58
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.39
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;10,588
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;10,225
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;10,029
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.57
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.72
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;7,606
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;7,346
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;7,145
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.58
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.94
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;17,381
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;16,949
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
33 Asturias;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.51
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;10,060
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;9,839
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
33 Asturias;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.80
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;7,321
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;7,110
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
33 Asturias;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.12
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;20,596
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;20,028
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;19,666
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.24
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.48
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;12,509
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;12,178
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;12,001
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.35
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.94
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;8,087
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;7,850
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;7,665
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.07
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.78
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;20,847
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;20,448
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
33 Asturias;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.09
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;12,600
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;12,407
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
33 Asturias;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.47
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;8,247
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;8,041
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
33 Asturias;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.50
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;11,518
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;10,807
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;10,397
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.83
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.27
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,880
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;6,449
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;6,220
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.74
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.41
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,638
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;4,358
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;4,177
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.96
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.06
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;12,803
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;12,330
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
33 Asturias;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.31
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;7,657
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;7,392
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
33 Asturias;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.54
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;5,146
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;4,938
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
33 Asturias;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.96
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
33 Asturias;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;10,394
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;9,962
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;9,706
05 Ávila;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.84
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.38
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,737
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;6,463
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;6,318
05 Ávila;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.93
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.78
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,657
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;3,499
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;3,388
05 Ávila;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.68
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.64
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;10,352
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;10,053
05 Ávila;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
05 Ávila;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.11
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;6,704
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;6,536
05 Ávila;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
05 Ávila;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.49
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,648
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;3,517
05 Ávila;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
05 Ávila;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.41
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;575
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;533
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;505
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92.70
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87.83
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;375
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;349
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;334
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.07
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.07
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;200
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;184
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;171
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.00
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85.50
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;501
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;471
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
05 Ávila;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94.01
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;347
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;331
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
05 Ávila;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.39
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;154
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;140
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
05 Ávila;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;90.91
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,496
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;1,423
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;1,386
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.12
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.65
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;900
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;859
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;840
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.44
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.33
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;596
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;564
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;546
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.63
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.61
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,435
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;1,394
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
05 Ávila;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.14
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;860
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;835
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
05 Ávila;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.09
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;575
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;559
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
05 Ávila;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.22
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,775
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;2,687
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;2,631
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.83
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.81
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,765
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;1,708
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;1,675
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.77
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.90
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,010
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;979
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;956
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.93
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.65
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,680
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;2,609
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
05 Ávila;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.35
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,675
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;1,639
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
05 Ávila;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.85
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,005
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;970
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
05 Ávila;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.52
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,327
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;3,231
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;3,170
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.11
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.28
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,175
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;2,118
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;2,087
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.38
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.95
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,152
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;1,113
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;1,083
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.61
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.01
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,298
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;3,228
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
05 Ávila;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.88
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,164
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;2,130
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
05 Ávila;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.43
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,134
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;1,098
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
05 Ávila;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.83
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,221
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;2,088
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;2,014
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.01
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.68
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,522
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;1,429
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1,382
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.89
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.80
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;699
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;659
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;632
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.28
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.41
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,438
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;2,351
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
05 Ávila;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.43
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,658
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;1,601
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
05 Ávila;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.56
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;780
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;750
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
05 Ávila;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.15
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
05 Ávila;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;40,159
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;38,488
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;37,467
06 Badajoz;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.84
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.30
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;25,732
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;24,741
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;24,182
06 Badajoz;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.15
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.98
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;14,427
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;13,747
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;13,285
06 Badajoz;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.29
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.08
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;39,960
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;38,841
06 Badajoz;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
06 Badajoz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.20
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;25,590
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;24,968
06 Badajoz;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
06 Badajoz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.57
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;14,370
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;13,873
06 Badajoz;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
06 Badajoz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.54
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,165
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;2,935
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2,799
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92.73
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;88.44
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,908
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1,766
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1,690
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92.56
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;88.57
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,257
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,169
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,109
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.00
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88.23
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,837
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2,703
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
06 Badajoz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.28
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,731
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1,656
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
06 Badajoz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.67
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,106
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,047
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
06 Badajoz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.67
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,821
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;7,475
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;7,279
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.58
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.07
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,626
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;4,427
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4,321
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.70
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.41
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,195
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3,048
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;2,958
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.40
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.58
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;7,385
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;7,173
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
06 Badajoz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.13
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,343
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4,221
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
06 Badajoz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.19
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,042
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;2,952
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
06 Badajoz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.04
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;11,546
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;11,150
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;10,859
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.57
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.05
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,291
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;7,077
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;6,930
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.06
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.05
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,255
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;4,073
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;3,929
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.72
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.34
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;11,269
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;10,955
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
06 Badajoz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.21
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;7,032
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;6,873
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
06 Badajoz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.74
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,237
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;4,082
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
06 Badajoz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.34
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;11,303
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;10,984
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;10,797
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.18
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.52
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,559
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;7,382
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;7,286
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.66
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.39
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,744
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;3,602
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;3,511
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.21
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.78
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;11,461
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;11,237
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
06 Badajoz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.05
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;7,665
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;7,549
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
06 Badajoz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.49
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,796
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;3,688
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
06 Badajoz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.15
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,324
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;5,944
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;5,733
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.99
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.65
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,348
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;4,089
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3,955
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.04
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.96
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,976
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1,855
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,778
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.88
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.98
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;7,008
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;6,773
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
06 Badajoz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.65
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,819
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;4,669
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
06 Badajoz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.89
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,189
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2,104
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
06 Badajoz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.12
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
06 Badajoz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;97,938
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;93,118
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;90,494
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.08
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.40
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;62,452
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;59,590
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;58,094
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.42
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.02
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;35,486
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;33,528
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;32,400
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.48
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.30
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;99,488
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;96,420
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.92
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;63,334
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;61,563
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.20
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;36,154
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;34,857
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.41
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,298
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;5,763
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;5,481
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.51
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87.03
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,082
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;3,763
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;3,600
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92.19
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;88.19
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,216
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;2,000
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,881
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90.25
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84.88
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;5,744
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;5,427
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94.48
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,781
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;3,597
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.13
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,963
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,830
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93.22
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;17,508
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;16,455
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;15,891
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.99
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.76
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;10,559
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;9,958
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;9,649
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.31
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.38
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;6,949
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;6,497
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;6,242
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.50
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.83
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;16,797
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;16,163
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.23
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;10,069
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;9,721
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.54
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;6,728
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;6,442
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.75
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;29,277
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;27,997
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;27,292
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.63
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.22
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;18,650
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;17,909
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;17,522
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.03
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.95
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;10,627
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;10,088
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;9,770
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.93
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.94
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;28,599
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;27,768
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.09
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;18,136
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;17,676
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.46
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;10,463
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;10,092
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.45
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;28,712
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;27,712
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;27,161
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.52
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.60
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;18,704
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;18,090
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;17,769
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.72
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.00
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;10,008
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;9,622
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;9,392
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.14
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.84
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;29,445
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;28,785
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.76
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;19,190
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;18,788
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.91
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;10,255
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;9,997
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.48
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;16,143
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;15,191
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;14,669
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.10
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.87
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;10,457
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;9,870
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;9,554
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.39
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.36
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,686
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;5,321
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;5,115
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.58
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.96
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;18,903
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;18,277
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.69
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;12,158
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;11,781
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.90
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;6,745
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;6,496
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.31
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
07 Balears, Illes;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;410,792
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;389,739
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;377,234
08 Barcelona;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.88
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.83
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;256,711
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;244,006
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;236,699
08 Barcelona;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.05
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.20
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;154,081
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;145,733
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;140,535
08 Barcelona;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.58
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.21
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;411,087
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;396,949
08 Barcelona;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
08 Barcelona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.56
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;256,633
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;248,332
08 Barcelona;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
08 Barcelona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.77
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;154,454
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;148,617
08 Barcelona;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
08 Barcelona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.22
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;31,673
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;28,549
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;26,754
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90.14
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84.47
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;19,769
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;17,857
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;16,762
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.33
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;84.79
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;11,904
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;10,692
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;9,992
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89.82
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;83.94
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;28,393
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;26,451
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
08 Barcelona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.16
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;17,857
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;16,650
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
08 Barcelona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.24
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;10,536
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;9,801
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
08 Barcelona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93.02
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;73,065
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;68,163
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;65,176
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.29
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.20
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;43,002
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;40,250
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;38,583
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.60
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.72
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;30,063
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;27,913
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;26,593
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.85
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88.46
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;71,017
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;67,651
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
08 Barcelona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.26
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;41,676
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;39,782
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
08 Barcelona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.46
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;29,341
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;27,869
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
08 Barcelona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.98
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;113,110
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;108,071
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;104,996
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.55
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.83
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;70,508
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;67,438
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;65,678
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.65
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.15
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;42,602
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;40,633
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;39,318
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.38
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.29
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;109,119
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;105,685
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
08 Barcelona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.85
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;67,612
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;65,646
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
08 Barcelona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.09
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;41,507
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;40,039
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
08 Barcelona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.46
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;121,724
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;117,930
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;115,568
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.88
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.94
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;77,728
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;75,416
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;74,043
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.03
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.26
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;43,996
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;42,514
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;41,525
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.63
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.38
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;123,844
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;121,103
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
08 Barcelona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.79
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;78,991
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;77,379
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
08 Barcelona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.96
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;44,853
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;43,724
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
08 Barcelona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.48
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;71,220
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;67,026
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;64,740
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.11
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.90
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;45,704
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;43,045
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;41,633
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.18
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.09
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;25,516
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;23,981
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;23,107
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.98
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.56
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;78,714
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;76,059
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
08 Barcelona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.63
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;50,497
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;48,875
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
08 Barcelona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.79
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;28,217
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;27,184
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
08 Barcelona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.34
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
08 Barcelona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;78,976
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;75,560
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;73,109
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.67
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.57
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;46,308
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;44,178
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;42,909
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.40
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.66
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;32,668
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;31,382
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;30,200
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.06
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.45
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;78,788
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;76,069
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.55
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;46,042
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;44,603
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.87
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;32,746
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;31,466
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.09
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,734
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;4,325
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;4,020
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.36
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84.92
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,890
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2,629
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2,445
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.97
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;84.60
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,844
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,696
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,575
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91.97
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85.41
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,399
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;4,048
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92.02
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,714
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2,491
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;91.78
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,685
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,557
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.40
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;11,515
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;10,840
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;10,374
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.14
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.09
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,539
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;6,135
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;5,910
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.82
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.38
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,976
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;4,705
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;4,464
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.55
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.71
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;10,945
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;10,424
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.24
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;6,223
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;5,956
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.71
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,722
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;4,468
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.62
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;21,446
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;20,703
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;20,104
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.54
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.74
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;12,289
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;11,810
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;11,519
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.10
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.73
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;9,157
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;8,893
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;8,585
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.12
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.75
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;20,333
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;19,679
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.78
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;11,615
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;11,289
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.19
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;8,718
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;8,390
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.24
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;27,263
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;26,584
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;26,046
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.51
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.54
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;15,693
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;15,297
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;15,045
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.48
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.87
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;11,570
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;11,287
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;11,001
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.55
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95.08
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;27,462
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;26,908
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.98
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;15,619
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;15,356
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.32
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;11,843
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;11,552
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.54
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;14,018
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;13,108
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;12,565
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.51
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.63
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;8,897
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;8,307
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;7,990
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.37
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.81
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,121
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;4,801
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;4,575
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.75
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.34
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;15,649
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;15,010
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.92
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;9,871
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;9,511
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.35
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;5,778
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;5,499
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
48 Bizkaia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.17
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
48 Bizkaia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;21,358
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;20,426
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;19,955
09 Burgos;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.64
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.43
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;13,154
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;12,599
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;12,349
09 Burgos;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.78
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.88
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;8,204
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;7,827
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;7,606
09 Burgos;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.40
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.71
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;21,210
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;20,671
09 Burgos;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
09 Burgos;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.46
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;13,076
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;12,785
09 Burgos;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
09 Burgos;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.77
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;8,134
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;7,886
09 Burgos;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
09 Burgos;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.95
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,179
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1,067
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1,000
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90.50
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84.82
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;707
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;645
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;606
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.23
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85.71
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;472
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;422
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;394
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89.41
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;83.47
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,061
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;982
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
09 Burgos;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92.55
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;670
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;621
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
09 Burgos;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;92.69
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;391
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;361
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
09 Burgos;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.33
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,042
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2,894
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;2,800
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.13
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.04
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,735
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1,651
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1,599
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.16
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.16
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,307
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1,243
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1,201
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.10
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.89
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,879
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;2,778
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
09 Burgos;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.49
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,635
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1,579
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
09 Burgos;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.57
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,244
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1,199
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
09 Burgos;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.38
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;5,738
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;5,570
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;5,470
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.07
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.33
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,437
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;3,338
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;3,295
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.12
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.87
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,301
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2,232
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2,175
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.00
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.52
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;5,451
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;5,342
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
09 Burgos;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.00
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,225
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;3,178
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
09 Burgos;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.54
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,226
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2,164
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
09 Burgos;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.21
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,836
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;6,637
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;6,537
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.09
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.63
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,239
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;4,132
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;4,083
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.48
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.32
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,597
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2,505
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2,454
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.46
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.49
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,889
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;6,767
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
09 Burgos;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.23
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,307
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;4,246
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
09 Burgos;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.58
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,582
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2,521
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
09 Burgos;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.64
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,563
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;4,258
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;4,148
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.32
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.91
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,036
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2,833
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2,766
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.31
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.11
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,527
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1,425
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,382
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.32
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.50
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,930
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;4,802
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
09 Burgos;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.40
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,239
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;3,161
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
09 Burgos;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.59
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,691
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1,641
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
09 Burgos;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.04
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
09 Burgos;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;24,516
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;23,553
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;22,945
10 Cáceres;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.07
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.59
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;15,265
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;14,706
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;14,365
10 Cáceres;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.34
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.10
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;9,251
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;8,847
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;8,580
10 Cáceres;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.63
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.75
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;24,489
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;23,821
10 Cáceres;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
10 Cáceres;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.27
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;15,233
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;14,862
10 Cáceres;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
10 Cáceres;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.56
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;9,256
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;8,959
10 Cáceres;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
10 Cáceres;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.79
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,707
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1,582
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1,514
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92.68
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;88.69
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,021
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;959
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;918
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.93
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.91
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;686
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;623
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;596
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90.82
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86.88
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,527
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1,456
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
10 Cáceres;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.35
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;938
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;897
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
10 Cáceres;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.63
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;589
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;559
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
10 Cáceres;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.91
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,347
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;4,176
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;4,060
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.07
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.40
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,497
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;2,411
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2,360
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.56
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.51
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,850
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1,765
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1,700
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.41
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.89
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,127
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;4,010
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
10 Cáceres;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.17
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,379
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2,323
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
10 Cáceres;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.65
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,748
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1,687
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
10 Cáceres;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.51
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,968
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;6,729
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;6,592
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.57
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.60
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,365
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;4,227
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;4,144
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.84
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.94
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,603
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2,502
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2,448
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.12
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.05
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,771
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;6,608
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
10 Cáceres;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.59
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,201
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;4,112
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
10 Cáceres;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.88
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,570
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2,496
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
10 Cáceres;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.12
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,241
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;7,036
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;6,894
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.17
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.21
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,627
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;4,507
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;4,430
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.41
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.74
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,614
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2,529
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2,464
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.75
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.26
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;7,324
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;7,176
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
10 Cáceres;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.98
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,640
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;4,556
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
10 Cáceres;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.19
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,684
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2,620
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
10 Cáceres;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.62
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,253
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;4,030
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;3,885
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.76
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.35
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,755
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2,602
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2,513
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.45
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.22
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,498
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1,428
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,372
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.33
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.59
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,740
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;4,571
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
10 Cáceres;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.43
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,075
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;2,974
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
10 Cáceres;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.72
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,665
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1,597
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
10 Cáceres;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.92
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
10 Cáceres;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;63,836
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;60,674
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;58,738
11 Cádiz;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.05
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.01
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;39,607
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;37,783
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;36,699
11 Cádiz;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.39
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.66
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;24,229
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;22,891
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;22,039
11 Cádiz;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.48
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.96
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;64,044
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;61,841
11 Cádiz;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
11 Cádiz;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.56
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;39,691
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;38,454
11 Cádiz;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
11 Cádiz;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.88
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;24,353
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;23,387
11 Cádiz;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
11 Cádiz;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.03
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,740
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;4,319
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;4,092
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.12
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86.33
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,765
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2,506
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2,372
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.63
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85.79
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,975
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,813
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,720
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91.80
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;87.09
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,276
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;4,018
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
11 Cádiz;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.97
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,514
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2,362
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
11 Cádiz;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.95
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,762
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,656
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
11 Cádiz;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93.98
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;11,966
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;11,307
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;10,880
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.49
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.92
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,825
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;6,494
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;6,280
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.15
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.01
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,141
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;4,813
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;4,600
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.62
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.48
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;11,479
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;11,021
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
11 Cádiz;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.01
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;6,571
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;6,336
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
11 Cádiz;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.42
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,908
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;4,685
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
11 Cádiz;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.46
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;19,276
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;18,439
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;17,902
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.66
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.87
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;11,817
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;11,362
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;11,069
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.15
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.67
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;7,459
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;7,077
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;6,833
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.88
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.61
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;18,677
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;18,063
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
11 Cádiz;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.71
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;11,396
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;11,050
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
11 Cádiz;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.96
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;7,281
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;7,013
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
11 Cádiz;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.32
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;18,656
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;17,975
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;17,545
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.35
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.04
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;12,041
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;11,622
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;11,379
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.52
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.50
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;6,615
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;6,353
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;6,166
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.04
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.21
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;19,085
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;18,590
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
11 Cádiz;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.41
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;12,207
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;11,941
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
11 Cádiz;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.82
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;6,878
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;6,649
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
11 Cádiz;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.67
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;9,198
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;8,634
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;8,319
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.87
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.44
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,159
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;5,799
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;5,599
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.15
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.91
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,039
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2,835
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2,720
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.29
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.50
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;10,527
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;10,149
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
11 Cádiz;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.41
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;7,003
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;6,765
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
11 Cádiz;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.60
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,524
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;3,384
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
11 Cádiz;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.03
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
11 Cádiz;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;37,937
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;36,449
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;35,523
39 Cantabria;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.08
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.64
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;23,174
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;22,283
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;21,781
39 Cantabria;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.16
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.99
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;14,763
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;14,166
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;13,742
39 Cantabria;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.96
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.08
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;37,832
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;36,798
39 Cantabria;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
39 Cantabria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.27
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;23,070
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;22,513
39 Cantabria;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
39 Cantabria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.59
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;14,762
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;14,285
39 Cantabria;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
39 Cantabria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.77
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,134
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1,989
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1,882
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.21
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;88.19
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,309
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1,225
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1,167
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.58
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.15
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;825
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;764
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;715
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.61
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86.67
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,895
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1,786
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
39 Cantabria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94.25
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,174
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1,113
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
39 Cantabria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.80
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;721
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;673
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
39 Cantabria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93.34
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;5,530
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;5,271
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;5,123
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.32
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.64
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,162
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;3,008
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2,921
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.13
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.38
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,368
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;2,263
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;2,202
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.57
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.99
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;5,232
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;5,062
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
39 Cantabria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.75
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,957
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2,861
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
39 Cantabria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.75
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,275
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;2,201
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
39 Cantabria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.75
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;10,852
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;10,494
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;10,245
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.70
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.41
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,610
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;6,404
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;6,280
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.88
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.01
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,242
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;4,090
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;3,965
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.42
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.47
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;10,411
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;10,143
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
39 Cantabria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.43
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;6,337
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;6,203
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
39 Cantabria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.89
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,074
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;3,940
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
39 Cantabria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.71
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;12,211
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;11,907
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;11,702
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.51
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.83
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,605
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;7,438
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;7,345
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.80
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.58
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,606
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;4,469
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;4,357
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.03
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.59
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;12,242
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;12,009
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
39 Cantabria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.10
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;7,612
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;7,500
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
39 Cantabria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.53
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,630
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;4,509
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
39 Cantabria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.39
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,210
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;6,788
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;6,571
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.15
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.14
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,488
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;4,208
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;4,068
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.76
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.64
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,722
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2,580
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2,503
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.78
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.95
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;8,052
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;7,798
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
39 Cantabria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.85
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,990
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;4,836
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
39 Cantabria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.91
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,062
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2,962
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
39 Cantabria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.73
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
39 Cantabria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;39,980
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;38,062
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;36,951
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.20
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.42
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;24,457
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;23,328
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;22,703
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.38
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.83
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;15,523
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;14,734
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;14,248
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.92
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.79
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;40,262
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;38,986
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.83
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;24,638
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;23,911
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.05
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;15,624
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;15,075
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.49
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,772
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;2,534
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2,397
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.41
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86.47
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,757
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1,624
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1,541
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92.43
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87.71
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,015
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;910
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;856
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89.66
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84.33
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,540
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2,375
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.50
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,642
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1,540
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.79
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;898
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;835
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.98
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,617
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;6,228
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;6,032
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.12
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.16
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,817
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;3,588
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;3,483
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.00
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.25
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,800
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;2,640
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;2,549
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.29
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.04
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,432
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;6,204
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.46
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,700
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;3,572
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.54
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,732
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;2,632
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.34
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;11,986
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;11,516
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;11,220
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.08
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.61
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,305
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;7,027
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;6,870
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.19
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.05
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,681
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;4,489
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;4,350
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.90
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.93
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;11,562
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;11,239
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.21
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;6,981
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;6,811
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.56
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,581
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;4,428
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.66
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;12,118
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;11,743
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;11,494
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.91
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.85
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,529
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;7,315
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;7,172
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.16
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.26
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,589
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;4,428
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;4,322
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.49
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.18
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;12,418
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;12,133
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.70
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;7,770
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;7,601
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.82
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,648
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;4,532
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.50
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,487
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;6,041
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;5,808
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.12
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.53
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,049
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;3,774
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3,637
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.21
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.82
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,438
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2,267
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2,171
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.99
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.05
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;7,310
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;7,035
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.24
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,545
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;4,387
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.52
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,765
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2,648
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.77
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
12 Castellón/Castelló;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;28,383
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;27,304
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;26,522
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.20
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.44
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;18,233
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;17,565
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;17,108
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.34
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.83
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;10,150
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;9,739
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;9,414
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.95
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.75
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;28,354
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;27,476
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.90
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;18,143
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;17,636
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.21
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;10,211
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;9,840
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.37
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,897
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1,790
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1,694
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.36
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.30
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,200
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1,135
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1,069
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.58
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.08
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;697
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;655
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;625
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.97
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.67
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,745
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1,640
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.98
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,109
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1,037
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.51
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;636
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;603
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.81
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,991
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;4,801
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;4,649
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.19
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.15
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,004
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;2,885
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2,800
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.04
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.21
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,987
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1,916
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1,849
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.43
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.05
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,765
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;4,601
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.56
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,827
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2,737
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.82
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,938
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1,864
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.18
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;8,078
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;7,828
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;7,661
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.91
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.84
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,104
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;4,966
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;4,883
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.30
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.67
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,974
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2,862
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2,778
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.23
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.41
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;7,846
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;7,650
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.50
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,924
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;4,828
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.05
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,922
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2,822
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.58
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;8,468
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;8,252
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;8,085
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.45
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.48
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,571
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;5,444
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;5,355
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.72
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.12
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,897
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2,808
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2,730
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.93
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.24
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;8,526
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;8,343
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.85
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,585
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;5,487
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.25
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,941
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2,856
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.11
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,949
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;4,633
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;4,433
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.61
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.57
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,354
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;3,135
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3,001
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.47
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.48
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,595
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1,498
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,432
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.92
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.78
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;5,472
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;5,242
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.80
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,698
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;3,547
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.92
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,774
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1,695
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.55
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
13 Ciudad Real;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;46,337
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;44,405
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;43,172
14 Córdoba;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.83
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.17
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;29,516
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;28,352
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;27,678
14 Córdoba;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.06
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.77
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;16,821
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;16,053
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;15,494
14 Córdoba;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.43
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.11
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;46,231
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;44,834
14 Córdoba;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
14 Córdoba;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.98
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;29,414
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;28,649
14 Córdoba;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
14 Córdoba;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.40
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;16,817
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;16,185
14 Córdoba;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
14 Córdoba;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.24
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,362
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;3,072
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2,908
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.37
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86.50
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,052
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1,864
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1,765
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.84
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86.01
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,310
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,208
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,143
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.21
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;87.25
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,032
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2,850
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
14 Córdoba;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94.00
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,876
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1,765
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
14 Córdoba;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.08
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,156
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,085
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
14 Córdoba;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93.86
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;8,335
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;7,953
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;7,711
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.42
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.51
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,819
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;4,615
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4,492
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.77
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.21
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,516
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3,338
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;3,219
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.94
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.55
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;7,950
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;7,689
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
14 Córdoba;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.72
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,602
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4,471
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
14 Córdoba;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.15
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,348
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;3,218
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
14 Córdoba;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.12
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;13,198
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;12,768
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;12,473
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.74
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.51
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;8,389
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;8,139
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;7,999
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.02
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.35
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,809
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;4,629
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;4,474
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.26
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.03
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;12,767
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;12,422
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
14 Córdoba;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.30
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;8,037
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;7,864
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
14 Córdoba;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.85
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,730
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;4,558
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
14 Córdoba;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.36
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;13,946
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;13,551
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;13,272
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.17
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.17
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;9,182
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;8,944
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;8,790
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.41
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.73
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,764
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;4,607
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;4,482
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.70
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.08
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;13,992
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;13,688
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
14 Córdoba;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.83
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;9,167
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;9,001
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
14 Córdoba;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.19
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,825
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;4,687
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
14 Córdoba;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.14
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,496
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;7,061
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;6,808
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.20
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.82
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,074
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;4,790
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;4,632
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.40
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.29
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,422
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2,271
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2,176
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.77
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.84
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;8,490
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;8,185
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
14 Córdoba;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.41
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,732
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;5,548
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
14 Córdoba;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.79
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,758
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2,637
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
14 Córdoba;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.61
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
14 Córdoba;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;75,797
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;72,866
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;70,970
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.13
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.63
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;44,931
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;43,280
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;42,217
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.33
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.96
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;30,866
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;29,586
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;28,753
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.85
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.15
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;75,663
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;73,572
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.24
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;44,851
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;43,667
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.36
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;30,812
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;29,905
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.06
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,029
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;3,695
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3,484
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.71
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86.47
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,361
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2,159
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2,036
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.44
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86.23
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,668
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,536
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,448
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.09
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86.81
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,663
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3,439
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.88
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,150
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2,016
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.77
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,513
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,423
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.05
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;11,557
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;11,000
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;10,646
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.18
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.12
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,548
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;6,244
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;6,043
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.36
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.29
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,009
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;4,756
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;4,603
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.95
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.89
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;10,904
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;10,504
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.33
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;6,193
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;5,964
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.30
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,711
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;4,540
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.37
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;22,204
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;21,528
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;21,058
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.96
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.84
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;13,141
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;12,805
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;12,564
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.44
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.61
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;9,063
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;8,723
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;8,494
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.25
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.72
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;21,095
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;20,608
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.69
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;12,446
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;12,185
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.90
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;8,649
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;8,423
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.39
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;23,831
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;23,275
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;22,893
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.67
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;96.06
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;14,250
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;13,934
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;13,731
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.78
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.36
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;9,581
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;9,341
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;9,162
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.50
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95.63
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;24,427
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;23,980
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.17
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;14,615
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;14,378
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.38
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;9,812
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;9,602
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.86
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;14,176
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;13,368
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;12,889
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.30
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.92
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;8,631
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;8,138
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;7,843
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.29
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.87
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,545
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;5,230
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;5,046
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.32
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.00
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;15,574
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;15,041
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.58
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;9,447
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;9,124
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.58
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;6,127
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;5,917
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
15 Coruña, A;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.57
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
15 Coruña, A;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;12,784
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;12,245
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;11,949
16 Cuenca;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.78
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.47
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;8,417
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;8,080
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;7,924
16 Cuenca;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.00
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.14
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,367
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;4,165
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;4,025
16 Cuenca;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.37
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.17
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;12,739
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;12,405
16 Cuenca;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
16 Cuenca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.38
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;8,383
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;8,201
16 Cuenca;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
16 Cuenca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.83
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,356
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;4,204
16 Cuenca;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
16 Cuenca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.51
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;839
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;790
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;745
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.16
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;88.80
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;543
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;510
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;488
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.92
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.87
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;296
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;280
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;257
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.59
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86.82
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;776
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;721
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
16 Cuenca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92.91
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;500
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;471
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
16 Cuenca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.20
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;276
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;250
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
16 Cuenca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;90.58
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,153
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2,048
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;1,994
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.12
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.61
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,305
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1,250
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1,222
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.79
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.64
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;848
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;798
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;772
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.10
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.04
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,038
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;1,976
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
16 Cuenca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.96
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,262
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1,230
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
16 Cuenca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.46
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;776
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;746
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
16 Cuenca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.13
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,386
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;3,283
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;3,213
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.96
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.89
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,237
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;2,177
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;2,144
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.32
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.84
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,149
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;1,106
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;1,069
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.26
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.04
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,298
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;3,224
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
16 Cuenca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.76
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,151
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;2,115
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
16 Cuenca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.33
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,147
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;1,109
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
16 Cuenca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.69
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,974
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;3,862
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;3,806
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.18
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.77
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,657
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;2,591
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;2,564
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.52
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.50
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,317
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;1,271
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;1,242
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.51
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.31
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,953
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;3,889
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
16 Cuenca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.38
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,630
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;2,597
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
16 Cuenca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.75
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,323
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;1,292
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
16 Cuenca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.66
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,432
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;2,262
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;2,191
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.01
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.09
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,675
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;1,552
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1,506
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92.66
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.91
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;757
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;710
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;685
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.79
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.49
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,674
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;2,595
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
16 Cuenca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.05
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,840
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;1,788
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
16 Cuenca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.17
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;834
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;807
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
16 Cuenca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.76
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
16 Cuenca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;62,346
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;60,088
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;58,532
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.38
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.88
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;39,631
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;38,160
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;37,205
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.29
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.88
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;22,715
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;21,928
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;21,327
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.54
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.89
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;62,420
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;60,667
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.19
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;39,658
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;38,564
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.24
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;22,762
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;22,103
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.10
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,512
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;4,205
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3,960
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.20
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87.77
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,106
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2,888
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2,725
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92.98
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87.73
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,406
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,317
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,235
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.67
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;87.84
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,164
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3,871
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92.96
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,899
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2,705
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.31
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,265
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,166
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.17
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;9,195
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;8,806
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;8,504
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.77
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.49
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,755
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;5,513
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;5,333
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.79
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.67
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,440
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3,293
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;3,171
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.73
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.18
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;9,019
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;8,689
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.34
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,672
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;5,469
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.42
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,347
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;3,220
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.21
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;17,761
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;17,329
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;17,008
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.57
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.76
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;11,028
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;10,737
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;10,544
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.36
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.61
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;6,733
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;6,592
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;6,464
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.91
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;96.00
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;16,706
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;16,345
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.84
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;10,283
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;10,063
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.86
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;6,423
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;6,282
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.80
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;21,139
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;20,675
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;20,359
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.81
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;96.31
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;13,461
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;13,178
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;13,002
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.90
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.59
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;7,678
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;7,497
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;7,357
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.64
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95.82
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;21,550
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;21,230
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.52
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;13,735
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;13,553
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.67
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;7,815
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;7,677
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;98.23
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;9,739
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;9,073
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;8,701
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.16
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.34
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,281
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;5,844
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;5,601
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.04
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.17
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,458
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;3,229
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;3,100
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.38
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.65
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;10,981
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;10,532
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.91
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;7,069
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;6,774
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.83
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,912
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;3,758
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.06
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
20 Gipuzkoa;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;60,898
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;58,162
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;56,658
17 Girona;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.51
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.04
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;38,492
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;36,883
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;36,005
17 Girona;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.82
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.54
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;22,406
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;21,279
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;20,653
17 Girona;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.97
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.18
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;61,067
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;59,384
17 Girona;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
17 Girona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.24
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;38,721
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;37,726
17 Girona;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
17 Girona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.43
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;22,346
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;21,658
17 Girona;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
17 Girona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.92
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,174
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;3,863
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3,658
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92.55
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87.64
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,739
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2,542
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2,409
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92.81
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87.95
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,435
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,321
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,249
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.06
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;87.04
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,876
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3,670
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
17 Girona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94.69
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,579
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2,447
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
17 Girona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.88
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,297
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,223
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
17 Girona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.29
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;9,840
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;9,327
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;9,029
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.79
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.76
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,961
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;5,691
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;5,516
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.47
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.53
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,879
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3,636
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;3,513
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.74
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.56
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;9,375
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;9,036
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
17 Girona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.38
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,772
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;5,563
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
17 Girona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.38
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,603
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;3,473
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
17 Girona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.39
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;17,190
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;16,502
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;16,127
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.00
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.82
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;10,916
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;10,513
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;10,305
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.31
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.40
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;6,274
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;5,989
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;5,822
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.46
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.80
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;16,423
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;16,011
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
17 Girona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.49
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;10,408
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;10,174
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
17 Girona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.75
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;6,015
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;5,837
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
17 Girona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.04
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;18,079
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;17,510
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;17,209
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.85
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.19
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;11,420
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;11,085
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;10,926
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.07
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.67
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;6,659
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;6,425
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;6,283
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.49
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.35
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;18,480
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;18,138
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
17 Girona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.15
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;11,701
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;11,523
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
17 Girona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.48
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;6,779
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;6,615
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
17 Girona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.58
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;11,615
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;10,960
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;10,635
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.36
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.56
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,456
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;7,052
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;6,849
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.58
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.86
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,159
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;3,908
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;3,786
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.96
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.03
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;12,913
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;12,529
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
17 Girona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.03
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;8,261
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;8,019
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
17 Girona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.07
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,652
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;4,510
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
17 Girona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.95
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
17 Girona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;61,596
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;58,710
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;56,794
18 Granada;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.31
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.20
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;38,283
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;36,588
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;35,518
18 Granada;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.57
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.78
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;23,313
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;22,122
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;21,276
18 Granada;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.89
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.26
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;61,872
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;59,625
18 Granada;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
18 Granada;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.37
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;38,421
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;37,148
18 Granada;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
18 Granada;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.69
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;23,451
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;22,477
18 Granada;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
18 Granada;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.85
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,636
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;4,190
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3,951
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90.38
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85.22
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,847
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2,571
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2,442
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.31
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85.77
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,789
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,619
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,509
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90.50
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84.35
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,168
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3,902
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
18 Granada;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.62
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,600
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2,453
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
18 Granada;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.35
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,568
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,449
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
18 Granada;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.41
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;11,874
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;11,258
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;10,871
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.81
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.55
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,032
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;6,677
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;6,479
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.95
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.14
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,842
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;4,581
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;4,392
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.61
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.71
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;11,480
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;11,020
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
18 Granada;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.99
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;6,710
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;6,461
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
18 Granada;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.29
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,770
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;4,559
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
18 Granada;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.58
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;18,017
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;17,308
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;16,781
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.06
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.14
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;11,092
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;10,704
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;10,414
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.50
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.89
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;6,925
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;6,604
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;6,367
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.36
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.94
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;17,604
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;16,983
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
18 Granada;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.47
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;10,856
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;10,509
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
18 Granada;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.80
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;6,748
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;6,474
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
18 Granada;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.94
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;17,635
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;17,069
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;16,652
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.79
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.43
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;11,238
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;10,901
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;10,678
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.00
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.02
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;6,397
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;6,168
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;5,974
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.42
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.39
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;18,016
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;17,532
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
18 Granada;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.31
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;11,431
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;11,175
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
18 Granada;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.76
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;6,585
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;6,357
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
18 Granada;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.54
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;9,434
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;8,885
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;8,539
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.18
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.51
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,074
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;5,735
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;5,505
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.42
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.63
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,360
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;3,150
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;3,034
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.75
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.30
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;10,604
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;10,188
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
18 Granada;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.08
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;6,824
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;6,550
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
18 Granada;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.98
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,780
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;3,638
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
18 Granada;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.24
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
18 Granada;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;14,581
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;13,898
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;13,433
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.32
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.13
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;9,472
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;9,039
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;8,785
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.43
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.75
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,109
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;4,859
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;4,648
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.11
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.98
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;14,573
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;14,041
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.35
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;9,441
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;9,152
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.94
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;5,132
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;4,889
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.27
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,061
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;967
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;908
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.14
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85.58
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;685
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;621
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;590
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.66
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86.13
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;376
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;346
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;318
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.02
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84.57
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;977
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;909
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.04
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;629
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;594
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.44
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;348
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;315
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;90.52
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,268
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2,147
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;2,058
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.66
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.74
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,358
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1,280
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1,233
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.26
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.80
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;910
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;867
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;825
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.27
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.66
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,167
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;2,063
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.20
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,290
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1,234
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.66
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;877
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;829
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.53
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,347
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;4,174
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;4,067
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.02
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.56
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,784
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;2,682
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;2,623
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.34
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.22
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,563
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;1,492
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;1,444
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.46
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.39
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,161
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;4,046
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.24
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,664
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;2,602
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.67
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,497
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;1,444
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.46
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,443
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;4,299
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;4,191
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.76
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.33
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,956
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;2,866
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;2,807
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.96
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.96
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,487
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;1,433
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;1,384
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.37
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.07
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,554
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;4,427
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.21
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,998
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;2,928
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.67
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,556
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;1,499
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.34
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,462
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;2,311
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;2,209
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.87
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.72
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,689
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;1,590
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1,532
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.14
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.70
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;773
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;721
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;677
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.27
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;87.58
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,714
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;2,596
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.65
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,860
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;1,794
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.45
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;854
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;802
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
19 Guadalajara;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93.91
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
19 Guadalajara;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;26,086
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;24,916
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;24,151
21 Huelva;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.51
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.58
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;16,308
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;15,618
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;15,227
21 Huelva;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.77
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.37
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;9,778
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;9,298
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;8,924
21 Huelva;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.09
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.27
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;26,269
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;25,383
21 Huelva;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
21 Huelva;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.63
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;16,366
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;15,910
21 Huelva;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
21 Huelva;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.21
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;9,903
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;9,473
21 Huelva;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
21 Huelva;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.66
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,051
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1,871
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1,776
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.22
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86.59
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,209
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1,101
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1,062
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.07
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87.84
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;842
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;770
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;714
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91.45
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84.80
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,853
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1,745
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
21 Huelva;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94.17
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,083
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1,038
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
21 Huelva;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.84
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;770
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;707
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
21 Huelva;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;91.82
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,774
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;4,533
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;4,385
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.95
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.85
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,731
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;2,602
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2,532
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.28
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.71
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,043
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1,931
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1,853
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.52
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.70
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,616
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;4,452
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
21 Huelva;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.45
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,647
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2,566
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
21 Huelva;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.94
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,969
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1,886
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
21 Huelva;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.78
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,853
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;7,552
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;7,347
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.17
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.56
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,852
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;4,674
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;4,572
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.33
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.23
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,001
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2,878
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2,775
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.90
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.47
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;7,604
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;7,361
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
21 Huelva;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.80
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,642
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;4,520
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
21 Huelva;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.37
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,962
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2,841
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
21 Huelva;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.91
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,739
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;7,502
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;7,334
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.94
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.77
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,065
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;4,927
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;4,830
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.28
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.36
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,674
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2,575
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2,504
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.30
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.64
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;7,978
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;7,781
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
21 Huelva;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.53
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,200
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;5,095
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
21 Huelva;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.98
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,778
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2,686
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
21 Huelva;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.69
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,669
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;3,458
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;3,309
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.25
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.19
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,451
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2,314
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2,231
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.41
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.02
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,218
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1,144
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,078
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.92
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88.51
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,218
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;4,044
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
21 Huelva;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.87
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,794
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;2,691
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
21 Huelva;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.31
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,424
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1,353
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
21 Huelva;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.01
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
21 Huelva;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;14,549
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;13,944
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;13,547
22 Huesca;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.84
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.11
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;8,827
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;8,453
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;8,247
22 Huesca;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.76
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.43
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,722
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;5,491
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;5,300
22 Huesca;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.96
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.62
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;14,462
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;14,009
22 Huesca;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
22 Huesca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.87
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;8,762
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;8,523
22 Huesca;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
22 Huesca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.27
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;5,700
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;5,486
22 Huesca;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
22 Huesca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.25
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;829
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;764
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;716
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92.16
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86.37
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;511
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;471
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;442
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92.17
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86.50
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;318
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;293
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;274
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.14
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86.16
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;728
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;667
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
22 Huesca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;91.62
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;450
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;411
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
22 Huesca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;91.33
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;278
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;256
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
22 Huesca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.09
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,178
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2,078
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;2,013
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.41
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.42
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,218
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1,153
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1,121
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.66
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.04
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;960
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;925
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;892
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.35
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.92
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,037
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;1,970
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
22 Huesca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.71
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,150
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1,120
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
22 Huesca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.39
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;887
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;850
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
22 Huesca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.83
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,990
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;3,863
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;3,781
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.82
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.76
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,415
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;2,339
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;2,291
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.85
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.87
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,575
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;1,524
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;1,490
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.76
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.60
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,850
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;3,757
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
22 Huesca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.58
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,296
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;2,240
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
22 Huesca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.56
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,554
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;1,517
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
22 Huesca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.62
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,534
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;4,412
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;4,330
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.31
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.50
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,768
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;2,695
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;2,659
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.36
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.06
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,766
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;1,717
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;1,671
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.23
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.62
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,570
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;4,476
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
22 Huesca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.94
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,790
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;2,747
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
22 Huesca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.46
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,780
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;1,729
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
22 Huesca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.13
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,018
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;2,827
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;2,707
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.67
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.70
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,915
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;1,795
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1,734
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.73
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.55
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,103
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1,032
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;973
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.56
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88.21
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,277
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;3,139
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
22 Huesca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.79
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,076
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;2,005
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
22 Huesca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.58
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,201
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1,134
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
22 Huesca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.42
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
22 Huesca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;35,370
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;33,812
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;32,781
23 Jaén;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.60
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.68
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;22,495
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;21,532
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;20,963
23 Jaén;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.72
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.19
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;12,875
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;12,280
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;11,818
23 Jaén;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.38
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.79
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;35,177
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;34,015
23 Jaén;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
23 Jaén;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.70
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;22,356
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;21,701
23 Jaén;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
23 Jaén;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.07
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;12,821
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;12,314
23 Jaén;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
23 Jaén;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.05
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,767
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;2,520
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2,386
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.07
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86.23
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,717
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1,574
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1,489
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.67
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86.72
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,050
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;946
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;897
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90.10
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85.43
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,435
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2,287
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
23 Jaén;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.92
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,518
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1,420
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
23 Jaén;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.54
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;917
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;867
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
23 Jaén;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.55
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,660
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;6,361
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;6,161
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.51
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.51
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,858
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;3,682
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;3,584
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.44
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.90
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,802
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;2,679
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;2,577
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.61
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.97
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,329
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;6,104
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
23 Jaén;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.44
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,674
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;3,558
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
23 Jaén;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.84
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,655
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;2,546
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
23 Jaén;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.89
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;9,840
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;9,496
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;9,233
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.50
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.83
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,264
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;6,060
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;5,934
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.74
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.73
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,576
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;3,436
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;3,299
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.09
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.25
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;9,564
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;9,268
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
23 Jaén;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.91
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;6,045
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;5,899
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
23 Jaén;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.58
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,519
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;3,369
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
23 Jaén;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.74
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;10,506
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;10,180
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;9,960
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.90
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.80
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,868
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;6,664
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;6,541
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.03
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.24
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,638
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;3,516
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;3,419
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.65
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.98
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;10,549
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;10,309
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
23 Jaén;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.72
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;6,888
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;6,755
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
23 Jaén;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.07
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,661
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;3,554
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
23 Jaén;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.08
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;5,597
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;5,255
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;5,041
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.89
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.07
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,788
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;3,552
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3,415
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.77
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.15
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,809
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1,703
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,626
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.14
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.88
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,300
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;6,047
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
23 Jaén;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.98
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,231
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;4,069
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
23 Jaén;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.17
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,069
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1,978
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
23 Jaén;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.60
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
23 Jaén;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;28,009
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;26,897
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;26,168
24 León;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.03
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.43
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;17,175
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;16,486
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;16,088
24 León;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.99
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.67
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;10,834
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;10,411
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;10,080
24 León;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.10
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.04
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;27,875
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;27,063
24 León;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
24 León;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.09
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;17,048
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;16,605
24 León;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
24 León;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.40
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;10,827
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;10,458
24 León;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
24 León;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.59
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
24 León;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
24 León;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,584
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1,428
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1,333
24 León;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90.15
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84.15
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,007
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;912
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;854
24 León;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.57
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;84.81
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;577
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;516
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;479
24 León;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89.43
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;83.02
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,413
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1,309
24 León;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
24 León;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92.64
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;897
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;835
24 León;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
24 León;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.09
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;516
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;474
24 León;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
24 León;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;91.86
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,834
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;3,661
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;3,538
24 León;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.49
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.28
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,211
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;2,104
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2,041
24 León;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.16
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.31
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,623
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1,557
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1,497
24 León;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.93
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.24
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,628
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;3,486
24 León;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
24 León;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.09
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,080
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2,009
24 León;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
24 León;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.59
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,548
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1,477
24 León;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
24 León;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.41
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,696
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;7,445
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;7,279
24 León;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.74
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.58
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,663
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;4,530
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;4,448
24 León;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.15
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.39
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,033
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2,915
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2,831
24 León;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.11
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.34
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;7,302
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;7,117
24 León;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
24 León;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.47
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,396
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;4,295
24 León;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
24 León;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.70
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,906
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2,822
24 León;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
24 León;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.11
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;8,981
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;8,775
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;8,621
24 León;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.71
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.99
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,544
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;5,413
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;5,332
24 León;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.64
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.18
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,437
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;3,362
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;3,289
24 León;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.82
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95.69
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;8,994
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;8,825
24 León;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
24 León;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.12
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,562
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;5,478
24 León;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
24 León;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.49
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,432
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;3,347
24 León;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
24 León;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.52
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;5,914
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;5,588
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;5,397
24 León;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.49
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.26
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,750
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;3,527
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3,413
24 León;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.05
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.01
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,164
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2,061
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,984
24 León;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.24
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.68
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,538
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;6,326
24 León;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
24 León;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.76
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,113
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;3,988
24 León;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
24 León;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.96
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,425
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2,338
24 León;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
24 León;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.41
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
24 León;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;28,527
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;27,294
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;26,605
25 Lleida;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.68
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.26
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;17,913
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;17,165
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;16,774
25 Lleida;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.82
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.64
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;10,614
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;10,129
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;9,831
25 Lleida;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.43
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.62
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;28,290
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;27,503
25 Lleida;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
25 Lleida;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.22
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;17,790
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;17,323
25 Lleida;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
25 Lleida;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.37
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;10,500
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;10,180
25 Lleida;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
25 Lleida;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.95
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,106
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1,910
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1,808
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90.69
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85.85
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,357
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1,228
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1,164
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.49
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85.78
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;749
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;682
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;644
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91.05
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85.98
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,823
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1,715
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
25 Lleida;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94.08
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,189
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1,119
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
25 Lleida;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.11
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;634
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;596
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
25 Lleida;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.01
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,312
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;4,085
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;3,957
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.74
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.77
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,555
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;2,432
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2,362
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.19
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.45
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,757
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1,653
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1,595
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.08
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.78
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,146
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;3,989
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
25 Lleida;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.21
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,475
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2,382
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
25 Lleida;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.24
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,671
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1,607
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
25 Lleida;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.17
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,535
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;7,283
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;7,120
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.66
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.49
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,836
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;4,670
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;4,581
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.57
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.73
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,699
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2,613
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2,539
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.81
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.07
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;7,109
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;6,927
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
25 Lleida;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.44
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,503
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;4,401
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
25 Lleida;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.73
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,606
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2,526
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
25 Lleida;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.93
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;8,691
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;8,457
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;8,310
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.31
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.62
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,456
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;5,323
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;5,247
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.56
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.17
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,235
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;3,134
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;3,063
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.88
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.68
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;8,853
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;8,678
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
25 Lleida;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.02
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,607
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;5,510
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
25 Lleida;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.27
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,246
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;3,168
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
25 Lleida;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.60
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;5,883
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;5,559
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;5,410
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.49
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.96
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,709
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;3,512
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3,420
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.69
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.21
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,174
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2,047
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,990
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.16
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.54
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,359
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;6,194
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
25 Lleida;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.41
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,016
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;3,911
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
25 Lleida;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.39
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,343
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2,283
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
25 Lleida;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.44
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
25 Lleida;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;21,674
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;20,928
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;20,437
27 Lugo;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.56
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.29
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;13,152
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;12,695
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;12,413
27 Lugo;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.53
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.38
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;8,522
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;8,233
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;8,024
27 Lugo;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.61
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.16
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;21,601
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;21,070
27 Lugo;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
27 Lugo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.54
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;13,077
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;12,772
27 Lugo;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
27 Lugo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.67
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;8,524
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;8,298
27 Lugo;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
27 Lugo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.35
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,085
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1,007
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;960
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92.81
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;88.48
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;640
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;594
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;575
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92.81
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.84
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;445
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;413
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;385
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.81
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86.52
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;951
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;906
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
27 Lugo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.27
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;548
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;528
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
27 Lugo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.35
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;403
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;378
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
27 Lugo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93.80
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,273
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;3,145
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;3,064
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.09
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.61
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,902
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1,837
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1,797
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.58
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.48
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,371
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1,308
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1,267
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.40
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.41
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,031
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;2,941
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
27 Lugo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.03
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,772
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1,724
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
27 Lugo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.29
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,259
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1,217
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
27 Lugo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.66
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,076
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;5,927
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;5,810
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.55
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.62
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,663
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;3,572
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;3,502
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.52
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.60
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,413
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2,355
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2,308
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.60
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95.65
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;5,966
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;5,839
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
27 Lugo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.87
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,582
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;3,509
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
27 Lugo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.96
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,384
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2,330
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
27 Lugo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.73
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,924
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;6,767
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;6,661
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.73
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;96.20
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,240
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;4,148
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;4,086
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.83
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.37
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,684
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2,619
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2,575
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.58
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95.94
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,878
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;6,769
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
27 Lugo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.42
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,220
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;4,156
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
27 Lugo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.48
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,658
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2,613
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
27 Lugo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;98.31
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,316
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;4,082
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;3,942
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.58
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.33
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,707
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2,544
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2,453
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.98
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.62
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,609
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1,538
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,489
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.59
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.54
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,775
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;4,615
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
27 Lugo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.65
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,955
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;2,855
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
27 Lugo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.62
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,820
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1,760
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
27 Lugo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.70
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
27 Lugo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;435,183
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;412,971
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;399,251
28 Madrid;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.90
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.74
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;272,288
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;259,029
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;251,172
28 Madrid;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.13
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.24
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;162,895
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;153,942
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;148,079
28 Madrid;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.50
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.90
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;435,499
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;419,865
28 Madrid;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
28 Madrid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.41
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;272,099
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;263,114
28 Madrid;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
28 Madrid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.70
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;163,400
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;156,751
28 Madrid;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
28 Madrid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.93
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;31,040
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;27,905
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;26,091
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;89.90
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84.06
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;18,504
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;16,681
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;15,595
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.15
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;84.28
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;12,536
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;11,224
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;10,496
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89.53
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;83.73
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;27,897
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;25,903
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
28 Madrid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92.85
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;16,767
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;15,555
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
28 Madrid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;92.77
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;11,130
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;10,348
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
28 Madrid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.97
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;77,508
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;72,254
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;69,160
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.22
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.23
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;45,371
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;42,332
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;40,624
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.30
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.54
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;32,137
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;29,922
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;28,536
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.11
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88.79
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;75,344
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;71,799
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
28 Madrid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.29
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;43,903
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;41,946
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
28 Madrid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.54
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;31,441
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;29,853
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
28 Madrid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.95
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;123,254
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;117,878
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;114,330
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.64
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.76
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;76,353
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;73,118
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;71,185
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.76
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.23
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;46,901
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;44,760
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;43,145
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.44
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.99
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;119,480
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;115,499
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
28 Madrid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.67
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;73,489
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;71,309
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
28 Madrid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.03
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;45,991
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;44,190
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
28 Madrid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.08
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;125,020
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;120,615
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;117,764
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.48
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.20
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;80,401
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;77,811
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;76,209
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.78
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.79
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;44,619
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;42,804
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;41,555
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.93
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.13
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;128,010
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;124,729
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
28 Madrid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.44
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;82,194
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;80,346
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
28 Madrid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.75
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;45,816
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;44,383
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
28 Madrid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.87
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;78,361
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;74,319
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;71,906
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.84
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.76
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;51,659
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;49,087
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;47,559
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.02
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.06
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;26,702
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;25,232
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;24,347
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.49
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.18
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;84,768
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;81,935
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
28 Madrid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.66
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;55,746
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;53,958
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
28 Madrid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.79
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;29,022
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;27,977
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
28 Madrid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.40
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
28 Madrid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;137,849
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;130,457
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;125,511
29 Málaga;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.64
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.05
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;84,419
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;80,167
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;77,443
29 Málaga;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.96
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.74
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;53,430
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;50,290
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;48,068
29 Málaga;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.12
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.96
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;138,689
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;133,121
29 Málaga;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
29 Málaga;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.99
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;84,893
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;81,798
29 Málaga;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
29 Málaga;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.35
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;53,796
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;51,323
29 Málaga;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
29 Málaga;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.40
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;10,591
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;9,601
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;9,008
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90.65
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85.05
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,442
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;5,864
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;5,515
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.03
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85.61
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,149
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;3,737
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;3,493
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90.07
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84.19
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;9,506
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;8,843
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
29 Málaga;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.03
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,880
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;5,481
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
29 Málaga;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.21
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,626
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;3,362
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
29 Málaga;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.72
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;26,671
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;25,026
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;23,950
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.83
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.80
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;15,333
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;14,448
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;13,855
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.23
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.36
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;11,338
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;10,578
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;10,095
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.30
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.04
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;25,545
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;24,373
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
29 Málaga;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.41
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;14,672
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;14,032
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
29 Málaga;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.64
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;10,873
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;10,341
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
29 Málaga;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.11
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;41,245
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;39,300
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;37,975
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.28
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.07
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;24,856
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;23,777
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;23,114
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.66
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.99
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;16,389
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;15,523
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;14,861
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.72
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.68
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;40,630
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;39,139
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
29 Málaga;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.33
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;24,370
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;23,597
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
29 Málaga;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.83
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;16,260
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;15,542
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
29 Málaga;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.58
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;38,960
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;37,430
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;36,330
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.07
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.25
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;24,516
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;23,637
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;23,041
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.41
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.98
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;14,444
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;13,793
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;13,289
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.49
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.00
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;40,015
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;38,786
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
29 Málaga;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.93
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;25,029
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;24,370
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
29 Málaga;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.37
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;14,986
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;14,416
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
29 Málaga;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.20
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;20,382
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;19,100
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;18,248
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.71
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.53
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;13,272
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;12,441
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;11,918
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.74
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.80
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;7,110
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;6,659
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;6,330
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.66
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.03
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;22,993
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;21,980
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
29 Málaga;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.59
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;14,942
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;14,318
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
29 Málaga;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.82
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;8,051
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;7,662
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
29 Málaga;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.17
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
29 Málaga;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;95,443
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;91,475
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;87,899
30 Murcia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.84
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.10
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;59,872
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;57,475
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;55,336
30 Murcia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.00
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.42
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;35,571
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;34,000
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;32,563
30 Murcia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.58
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.54
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;95,898
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;91,967
30 Murcia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
30 Murcia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.90
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;60,089
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;57,751
30 Murcia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
30 Murcia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.11
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;35,809
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;34,216
30 Murcia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
30 Murcia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.55
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,676
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;7,082
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;6,605
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92.26
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86.05
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,761
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;4,389
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;4,104
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92.19
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86.20
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,915
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;2,693
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;2,501
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.38
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85.80
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,973
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;6,475
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
30 Murcia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92.86
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,338
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;4,046
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
30 Murcia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.27
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,635
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;2,429
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
30 Murcia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.18
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;16,903
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;16,094
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;15,328
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.21
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.68
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;9,949
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;9,499
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;9,087
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.48
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.34
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;6,954
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;6,595
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;6,241
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.84
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.75
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;16,318
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;15,495
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
30 Murcia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94.96
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;9,623
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;9,171
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
30 Murcia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.30
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;6,695
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;6,324
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
30 Murcia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.46
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;26,966
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;26,057
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;25,145
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.63
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.25
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;16,785
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;16,254
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;15,700
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.84
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.54
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;10,181
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;9,803
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;9,445
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.29
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.77
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;26,310
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;25,320
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
30 Murcia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.24
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;16,295
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;15,700
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
30 Murcia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.35
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;10,015
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;9,620
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
30 Murcia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.06
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;28,553
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;27,755
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;26,960
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.21
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.42
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;18,196
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;17,741
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;17,251
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.50
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.81
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;10,357
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;10,014
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;9,709
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.69
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.74
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;28,846
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;27,978
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
30 Murcia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.99
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;18,376
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;17,851
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
30 Murcia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.14
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;10,470
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;10,127
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
30 Murcia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.72
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;15,345
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;14,487
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;13,861
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.41
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.33
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;10,181
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;9,592
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;9,194
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.21
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.31
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,164
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;4,895
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;4,667
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.79
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.38
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;17,451
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;16,699
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
30 Murcia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.69
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;11,457
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;10,983
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
30 Murcia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.86
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;5,994
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;5,716
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
30 Murcia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.36
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
30 Murcia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;42,193
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;40,141
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;38,760
31 Navarra;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.14
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.86
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;26,630
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;25,316
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;24,468
31 Navarra;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.07
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.88
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;15,563
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;14,825
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;14,292
31 Navarra;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.26
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.83
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;41,930
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;40,357
31 Navarra;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
31 Navarra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.25
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;26,486
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;25,489
31 Navarra;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
31 Navarra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.24
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;15,444
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;14,868
31 Navarra;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
31 Navarra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.27
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,132
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;2,830
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2,646
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90.36
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84.48
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,132
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1,915
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1,785
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;89.82
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;83.72
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,000
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;915
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;861
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91.50
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86.10
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,843
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2,626
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
31 Navarra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92.37
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,961
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1,798
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
31 Navarra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;91.69
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;882
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;828
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
31 Navarra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93.88
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,624
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;6,223
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;5,956
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.95
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.92
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,090
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;3,815
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;3,656
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.28
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.39
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,534
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;2,408
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;2,300
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.03
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.77
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,285
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;5,997
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
31 Navarra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.42
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,847
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;3,670
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
31 Navarra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.40
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,438
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;2,327
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
31 Navarra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.45
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;11,788
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;11,309
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;10,946
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.94
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.86
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,205
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;6,910
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;6,704
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.91
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.05
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,583
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;4,399
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;4,242
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.99
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.56
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;11,177
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;10,779
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
31 Navarra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.44
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;6,815
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;6,585
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
31 Navarra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.63
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,362
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;4,194
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
31 Navarra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.15
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;13,338
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;12,948
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;12,661
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.08
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.92
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;8,502
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;8,266
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;8,097
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.22
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.24
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,836
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;4,682
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;4,564
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.82
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.38
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;13,510
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;13,171
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
31 Navarra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.49
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;8,627
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;8,419
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
31 Navarra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.59
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,883
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;4,752
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
31 Navarra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.32
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,311
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;6,831
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;6,551
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.43
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.60
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,701
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;4,410
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;4,226
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.81
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.90
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,610
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2,421
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2,325
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.76
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.08
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;8,115
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;7,784
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
31 Navarra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.92
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,236
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;5,017
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
31 Navarra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.82
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,879
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2,767
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
31 Navarra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.11
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
31 Navarra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;19,793
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;18,960
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;18,470
32 Ourense;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.79
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.32
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;12,157
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;11,648
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;11,373
32 Ourense;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.81
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.55
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;7,636
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;7,312
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;7,097
32 Ourense;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.76
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.94
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;19,684
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;19,146
32 Ourense;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
32 Ourense;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.27
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;12,038
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;11,730
32 Ourense;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
32 Ourense;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.44
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;7,646
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;7,416
32 Ourense;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
32 Ourense;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.99
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,082
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;990
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;933
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.50
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86.23
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;672
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;610
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;580
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.77
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86.31
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;410
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;380
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;353
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.68
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86.10
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;954
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;894
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
32 Ourense;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.71
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;585
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;552
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
32 Ourense;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.36
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;369
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;342
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
32 Ourense;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.68
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,087
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2,924
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;2,830
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.72
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.67
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,777
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1,676
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1,624
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.32
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.39
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,310
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1,248
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1,206
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.27
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.06
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,920
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;2,820
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
32 Ourense;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.58
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,671
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1,614
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
32 Ourense;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.59
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,249
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1,206
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
32 Ourense;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.56
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;5,707
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;5,514
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;5,410
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.62
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.80
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,515
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;3,402
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;3,346
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.79
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.19
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,192
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2,112
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2,064
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.35
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.16
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;5,439
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;5,323
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
32 Ourense;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.87
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,322
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;3,259
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
32 Ourense;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.10
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,117
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2,064
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
32 Ourense;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.50
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,173
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;6,032
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;5,931
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.72
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;96.08
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,844
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;3,773
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;3,716
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;98.15
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.67
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,329
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2,259
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2,215
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.99
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95.11
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,249
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;6,136
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
32 Ourense;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.19
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,884
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;3,821
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
32 Ourense;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.38
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,365
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2,315
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
32 Ourense;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.89
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,744
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;3,500
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;3,366
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.48
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.90
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,349
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2,187
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2,107
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.10
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.70
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,395
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1,313
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,259
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.12
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.25
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,122
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;3,973
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
32 Ourense;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.39
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,576
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;2,484
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
32 Ourense;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.43
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,546
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1,489
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
32 Ourense;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.31
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
32 Ourense;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;8,978
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;8,592
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;8,373
34 Palencia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.70
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.26
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,652
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;5,406
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;5,281
34 Palencia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.65
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.44
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,326
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;3,186
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;3,092
34 Palencia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.79
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.96
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;8,849
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;8,618
34 Palencia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
34 Palencia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.39
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,555
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;5,422
34 Palencia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
34 Palencia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.61
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,294
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;3,196
34 Palencia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
34 Palencia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.02
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;485
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;436
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;412
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;89.90
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84.95
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;311
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;281
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;261
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.35
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;83.92
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;174
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;155
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;151
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89.08
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86.78
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;398
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;377
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
34 Palencia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94.72
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;256
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;240
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
34 Palencia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.75
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;142
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;137
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
34 Palencia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.48
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,220
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;1,162
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;1,126
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.25
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.30
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;733
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;698
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;677
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.23
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.36
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;487
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;464
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;449
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.28
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.20
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,138
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;1,097
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
34 Palencia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.40
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;685
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;659
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
34 Palencia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.20
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;453
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;438
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
34 Palencia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.69
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,351
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;2,281
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;2,236
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.02
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.11
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,418
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;1,371
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;1,352
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.69
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.35
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;933
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;910
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;884
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.53
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.75
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,263
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;2,217
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
34 Palencia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.97
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,364
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;1,344
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
34 Palencia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.53
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;899
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;873
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
34 Palencia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.11
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,863
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;2,782
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;2,736
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.17
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.56
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,803
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;1,756
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;1,731
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.39
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.01
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,060
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;1,026
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;1,005
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.79
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.81
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,768
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;2,722
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
34 Palencia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.34
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,714
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;1,687
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
34 Palencia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.42
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,054
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;1,035
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
34 Palencia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;98.20
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,059
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;1,931
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;1,863
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.78
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.48
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,387
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;1,300
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1,260
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.73
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.84
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;672
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;631
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;603
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.90
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.73
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,282
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;2,205
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
34 Palencia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.63
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,536
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;1,492
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
34 Palencia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.14
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;746
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;713
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
34 Palencia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.58
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
34 Palencia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;72,219
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;68,729
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;66,576
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.17
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.19
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;45,395
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;43,288
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;42,058
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.36
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.65
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;26,824
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;25,441
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;24,518
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.84
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.40
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;72,233
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;69,821
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.66
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;45,293
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;43,925
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.98
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;26,940
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;25,896
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.12
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,800
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;4,320
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;4,067
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90.00
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84.73
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,934
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2,633
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2,491
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;89.74
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;84.90
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,866
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,687
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,576
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90.41
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84.46
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,283
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;4,014
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.72
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,629
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2,483
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.45
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,654
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,531
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.56
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;13,183
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;12,381
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;11,913
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.92
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.37
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,538
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;7,089
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;6,839
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.04
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.73
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,645
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;5,292
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;5,074
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.75
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.88
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;12,532
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;11,999
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.75
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;7,164
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;6,880
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.04
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;5,368
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;5,119
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.36
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;20,516
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;19,650
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;19,074
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.78
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.97
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;12,476
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;11,951
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;11,639
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.79
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.29
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;8,040
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;7,699
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;7,435
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.76
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.48
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;19,985
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;19,366
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.90
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;11,967
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;11,631
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.19
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;8,018
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;7,735
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.47
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;21,230
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;20,483
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;20,018
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.48
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.29
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;13,896
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;13,452
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;13,186
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.80
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.89
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;7,334
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;7,031
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;6,832
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.87
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.16
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;21,587
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;21,047
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.50
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;14,050
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;13,737
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.77
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;7,537
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;7,310
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.99
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;12,490
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;11,895
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;11,504
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.24
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.11
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;8,551
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;8,163
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;7,903
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.46
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.42
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,939
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;3,732
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;3,601
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.74
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.42
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;13,846
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;13,395
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.74
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;9,483
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;9,194
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.95
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,363
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;4,201
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.29
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
35 Palmas, Las;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;63,709
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;61,150
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;59,595
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.98
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.54
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;37,942
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;36,486
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;35,666
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.16
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.00
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;25,767
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;24,664
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;23,929
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.72
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.87
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;63,553
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;61,854
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.33
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;37,816
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;36,899
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.58
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;25,737
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;24,955
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.96
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,637
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;3,334
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3,142
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.67
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86.39
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,174
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2,010
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1,911
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92.46
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87.90
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,463
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,324
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,231
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90.50
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84.14
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,209
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3,004
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.61
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,990
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1,876
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.27
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,219
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,128
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.53
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;9,428
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;8,979
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;8,704
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.24
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.32
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,354
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;5,116
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4,978
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.55
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.98
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,074
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3,863
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;3,726
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.82
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.46
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;8,956
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;8,669
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.80
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,065
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4,926
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.26
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,891
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;3,743
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.20
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;18,581
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;17,985
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;17,608
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.79
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.76
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;10,937
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;10,596
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;10,401
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.88
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.10
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;7,644
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;7,389
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;7,207
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.66
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.28
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;17,705
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;17,312
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.78
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;10,344
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;10,131
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.94
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;7,361
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;7,181
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.55
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;20,509
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;19,949
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;19,614
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.27
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.64
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;12,319
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;12,002
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;11,835
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.43
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.07
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;8,190
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;7,947
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;7,779
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.03
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.98
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;20,890
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;20,497
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.12
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;12,515
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;12,310
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.36
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;8,375
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;8,187
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.76
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;11,554
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;10,903
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;10,527
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.37
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.11
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,158
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;6,762
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;6,541
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.47
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.38
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,396
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;4,141
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;3,986
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.20
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.67
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;12,793
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;12,372
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.71
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;7,902
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;7,656
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.89
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,891
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;4,716
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
36 Pontevedra;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.42
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
36 Pontevedra;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;20,508
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;19,593
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;19,057
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.54
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.92
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;12,632
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;12,072
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;11,761
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.57
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.10
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;7,876
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;7,521
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;7,296
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.49
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.64
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;20,423
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;19,790
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.90
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;12,568
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;12,197
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.05
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;7,855
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;7,593
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.66
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,316
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1,190
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1,116
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90.43
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84.80
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;872
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;790
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;750
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.60
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86.01
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;444
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;400
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;366
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90.09
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;82.43
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,181
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1,082
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;91.62
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;803
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;738
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;91.91
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;378
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;344
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;91.01
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,915
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2,762
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;2,660
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.75
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.25
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,670
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1,586
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1,531
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.97
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.68
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,245
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1,176
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1,129
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.46
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.68
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,836
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;2,710
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.56
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,633
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1,571
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.20
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,203
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1,139
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.68
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;5,634
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;5,459
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;5,346
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.89
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.89
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,430
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;3,326
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;3,259
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.97
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.01
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,204
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2,133
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2,087
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.78
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.69
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;5,346
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;5,220
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.64
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,206
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;3,130
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.63
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,140
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2,090
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.66
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,603
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;6,429
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;6,318
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.36
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.68
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,119
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;4,012
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;3,948
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.40
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.85
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,484
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2,417
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2,370
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.30
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95.41
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,665
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;6,537
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.08
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,174
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;4,098
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.18
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,491
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2,439
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.91
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,040
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;3,753
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;3,617
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92.90
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.53
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,541
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2,358
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2,273
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92.80
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.45
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,499
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1,395
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,344
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.06
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.66
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,395
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;4,241
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.50
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,752
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;2,660
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.66
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,643
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1,581
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
26 Rioja, La;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.23
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
26 Rioja, La;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;20,207
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;19,440
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;18,956
37 Salamanca;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.20
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.81
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;12,988
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;12,498
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;12,227
37 Salamanca;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.23
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.14
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;7,219
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;6,942
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;6,729
37 Salamanca;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.16
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.21
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;20,169
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;19,625
37 Salamanca;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
37 Salamanca;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.30
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;12,920
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;12,614
37 Salamanca;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
37 Salamanca;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.63
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;7,249
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;7,011
37 Salamanca;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
37 Salamanca;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.72
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,180
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1,087
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1,029
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92.12
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87.20
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;768
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;706
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;675
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.93
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87.89
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;412
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;381
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;354
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.48
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85.92
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,086
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1,020
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
37 Salamanca;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.92
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;721
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;683
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
37 Salamanca;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.73
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;365
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;337
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
37 Salamanca;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.33
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,009
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;2,862
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;2,777
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.11
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.29
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,781
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;1,697
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;1,648
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.28
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.53
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,228
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1,165
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1,129
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.87
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.94
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,833
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;2,737
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
37 Salamanca;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.61
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,659
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;1,605
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
37 Salamanca;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.75
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,174
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1,132
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
37 Salamanca;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.42
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;5,181
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;5,023
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;4,919
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.95
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.94
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,321
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;3,219
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;3,163
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.93
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.24
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,860
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;1,804
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;1,756
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.99
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.41
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,955
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;4,838
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
37 Salamanca;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.64
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,143
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;3,077
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
37 Salamanca;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.90
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,812
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;1,761
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
37 Salamanca;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.19
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,459
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;6,306
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;6,212
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.63
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;96.18
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,161
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;4,069
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;4,023
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.79
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.68
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,298
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;2,237
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;2,189
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.35
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95.26
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,492
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;6,381
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
37 Salamanca;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.29
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,169
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;4,115
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
37 Salamanca;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.70
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,323
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;2,266
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
37 Salamanca;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.55
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,378
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;4,162
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;4,019
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.07
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.80
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,957
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;2,807
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;2,718
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.93
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.92
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,421
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1,355
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,301
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.36
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.56
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,803
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;4,649
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
37 Salamanca;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.79
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,228
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;3,134
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
37 Salamanca;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.09
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,575
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;1,515
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
37 Salamanca;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.19
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
37 Salamanca;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;69,293
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;65,710
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;63,392
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.83
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.48
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;41,955
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;39,918
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;38,608
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.14
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.02
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;27,338
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;25,792
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;24,784
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.34
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.66
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;69,039
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;66,448
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.25
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;41,786
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;40,316
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.48
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;27,253
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;26,132
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.89
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,619
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;4,163
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3,882
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90.13
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84.04
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,704
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2,453
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2,318
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.72
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85.72
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,915
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,710
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,564
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89.30
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;81.67
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,091
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3,787
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92.57
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,463
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2,294
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.14
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,628
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,493
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;91.71
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;12,423
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;11,671
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;11,192
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.95
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.09
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,922
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;6,510
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;6,243
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.05
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.19
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,501
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;5,161
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;4,949
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.82
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.97
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;11,816
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;11,285
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.51
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;6,572
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;6,283
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.60
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;5,244
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;5,002
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.39
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;19,862
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;18,896
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;18,249
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.14
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.88
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;11,674
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;11,136
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;10,790
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.39
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.43
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;8,188
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;7,760
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;7,459
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.77
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.10
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;19,142
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;18,437
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.32
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;11,081
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;10,712
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.67
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;8,061
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;7,725
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.83
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;20,209
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;19,400
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;18,903
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.00
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.54
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;12,732
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;12,275
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;11,988
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.41
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.16
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;7,477
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;7,125
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;6,915
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.29
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.48
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;20,464
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;19,913
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.31
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;12,897
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;12,572
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.48
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;7,567
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;7,341
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.01
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;12,180
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;11,580
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;11,166
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.07
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.67
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,923
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;7,544
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;7,269
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.22
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.75
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,257
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;4,036
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;3,897
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.81
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.54
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;13,526
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;13,026
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.30
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;8,773
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;8,455
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.38
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,753
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;4,571
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.17
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
38 Santa Cruz de Tenerife;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;11,022
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;10,562
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;10,261
40 Segovia;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.83
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.10
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,149
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;6,859
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;6,695
40 Segovia;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.94
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.65
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,873
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;3,703
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;3,566
40 Segovia;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.61
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.07
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;10,966
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;10,634
40 Segovia;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
40 Segovia;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.97
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;7,083
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;6,897
40 Segovia;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
40 Segovia;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.37
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,883
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;3,737
40 Segovia;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
40 Segovia;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.24
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;633
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;586
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;556
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92.58
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87.84
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;426
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;398
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;378
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.43
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;88.73
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;207
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;188
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;178
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90.82
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85.99
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;559
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;521
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
40 Segovia;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.20
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;375
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;350
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
40 Segovia;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.33
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;184
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;171
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
40 Segovia;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.93
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,556
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;1,480
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;1,422
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.12
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.39
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;949
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;900
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;874
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.84
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.10
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;607
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;580
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;548
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.55
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.28
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,477
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;1,417
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
40 Segovia;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.94
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;899
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;870
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
40 Segovia;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.77
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;578
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;547
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
40 Segovia;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.64
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,849
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;2,750
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;2,685
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.53
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.24
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,806
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;1,741
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;1,717
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.40
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.07
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,043
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;1,009
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;968
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.74
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.81
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,759
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;2,686
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
40 Segovia;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.35
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,731
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;1,701
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
40 Segovia;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.27
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,028
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;985
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
40 Segovia;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.82
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,561
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;3,476
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;3,414
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.61
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.87
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,280
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;2,231
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;2,195
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.85
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.27
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,281
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;1,245
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;1,219
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.19
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95.16
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,496
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;3,430
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
40 Segovia;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.11
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,228
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;2,192
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
40 Segovia;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.38
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,268
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;1,238
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
40 Segovia;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.63
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,423
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;2,270
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;2,184
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.69
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.14
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,688
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;1,589
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1,531
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.14
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.70
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;735
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;681
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;653
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.65
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88.84
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,675
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;2,580
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
40 Segovia;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.45
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,850
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;1,784
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
40 Segovia;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.43
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;825
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;796
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
40 Segovia;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.48
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
40 Segovia;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;113,670
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;108,544
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;105,213
41 Sevilla;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.49
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.56
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;71,372
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;68,428
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;66,701
41 Sevilla;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.88
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.46
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;42,298
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;40,116
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;38,512
41 Sevilla;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.84
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.05
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;113,752
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;109,896
41 Sevilla;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
41 Sevilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.61
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;71,359
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;69,356
41 Sevilla;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
41 Sevilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.19
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;42,393
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;40,540
41 Sevilla;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
41 Sevilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.63
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;9,004
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;8,240
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;7,792
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.51
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86.54
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,325
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;4,883
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;4,639
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.70
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87.12
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,679
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;3,357
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;3,153
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91.25
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85.70
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;8,238
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;7,689
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
41 Sevilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.34
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,915
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;4,630
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
41 Sevilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.20
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,323
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;3,059
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
41 Sevilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.06
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;21,077
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;19,986
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;19,282
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.82
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.48
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;12,175
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;11,553
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;11,198
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.89
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.98
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;8,902
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;8,433
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;8,084
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.73
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.81
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;20,246
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;19,458
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
41 Sevilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.11
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;11,626
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;11,225
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
41 Sevilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.55
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;8,620
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;8,233
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
41 Sevilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.51
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;34,373
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;33,016
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;32,103
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.05
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.40
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;21,463
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;20,730
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;20,288
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.58
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.53
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;12,910
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;12,286
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;11,815
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.17
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.52
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;32,982
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;31,984
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
41 Sevilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.97
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;20,427
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;19,939
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
41 Sevilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.61
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;12,555
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;12,045
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
41 Sevilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.94
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;33,614
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;32,555
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;31,824
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.85
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.67
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;21,951
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;21,343
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;20,983
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.23
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.59
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;11,663
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;11,212
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;10,841
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.13
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.95
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;34,521
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;33,665
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
41 Sevilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.52
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;22,483
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;22,054
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
41 Sevilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.09
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;12,038
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;11,611
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
41 Sevilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.45
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;15,602
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;14,747
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;14,212
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.52
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.09
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;10,458
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;9,919
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;9,593
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.85
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.73
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,144
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;4,828
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;4,619
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.86
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.79
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;17,765
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;17,100
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
41 Sevilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.26
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;11,908
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;11,508
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
41 Sevilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.64
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;5,857
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;5,592
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
41 Sevilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.48
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
41 Sevilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;5,313
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;5,068
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;4,944
42 Soria;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.39
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.05
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,412
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;3,257
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;3,190
42 Soria;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.46
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.49
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,901
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;1,811
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;1,754
42 Soria;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.27
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.27
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;5,236
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;5,102
42 Soria;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
42 Soria;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.44
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,359
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;3,285
42 Soria;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
42 Soria;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.80
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,877
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;1,817
42 Soria;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
42 Soria;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.80
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;310
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;283
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;264
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.29
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85.16
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;200
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;182
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;169
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.00
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;84.50
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;110
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;101
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;95
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;91.82
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86.36
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;275
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;255
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
42 Soria;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92.73
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;183
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;168
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
42 Soria;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;91.80
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;92
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;87
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
42 Soria;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.57
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;793
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;760
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;745
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.84
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.95
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;460
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;444
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;435
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.52
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.57
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;333
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;316
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;310
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.89
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.09
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;740
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;721
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
42 Soria;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.43
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;433
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;422
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
42 Soria;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.46
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;307
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;299
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
42 Soria;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.39
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,372
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;1,333
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;1,306
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.16
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.19
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;863
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;837
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;826
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.99
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.71
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;509
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;496
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;480
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.45
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.30
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,322
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;1,294
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
42 Soria;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.88
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;825
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;811
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
42 Soria;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.30
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;497
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;483
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
42 Soria;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.18
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,688
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;1,632
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;1,606
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.68
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.14
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,102
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;1,068
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;1,058
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.91
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.01
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;586
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;564
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;548
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.25
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.52
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,655
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;1,629
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
42 Soria;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.43
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,073
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;1,063
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
42 Soria;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;99.07
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;582
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;566
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
42 Soria;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.25
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,150
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;1,060
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;1,023
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92.17
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;88.96
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;787
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;726
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;702
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92.25
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.20
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;363
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;334
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;321
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.01
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88.43
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,244
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;1,203
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
42 Soria;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.70
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;845
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;821
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
42 Soria;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.16
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;399
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;382
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
42 Soria;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.74
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
42 Soria;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;52,233
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;49,704
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;48,147
43 Tarragona;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.16
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.18
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;32,505
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;31,014
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;30,105
43 Tarragona;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.41
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.62
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;19,728
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;18,690
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;18,042
43 Tarragona;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.74
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.45
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;52,464
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;50,688
43 Tarragona;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
43 Tarragona;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.61
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;32,693
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;31,630
43 Tarragona;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
43 Tarragona;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.75
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;19,771
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;19,058
43 Tarragona;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
43 Tarragona;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.39
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,121
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;3,759
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3,538
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.22
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85.85
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,709
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2,492
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2,347
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.99
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86.64
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,412
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,267
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,191
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89.73
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84.35
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,766
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3,506
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
43 Tarragona;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.10
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,508
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2,331
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
43 Tarragona;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;92.94
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,258
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,175
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
43 Tarragona;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93.40
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;8,429
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;7,947
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;7,664
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.28
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.92
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,994
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;4,720
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4,566
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.51
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.43
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,435
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3,227
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;3,098
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.94
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.19
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;8,149
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;7,836
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
43 Tarragona;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.16
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,873
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4,693
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
43 Tarragona;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.31
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,276
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;3,143
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
43 Tarragona;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.94
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;15,021
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;14,426
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;14,017
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.04
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.32
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;9,233
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;8,875
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;8,653
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.12
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.72
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,788
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;5,551
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;5,364
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.91
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.67
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;14,466
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;14,013
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
43 Tarragona;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.87
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;8,854
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;8,614
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
43 Tarragona;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.29
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;5,612
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;5,399
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
43 Tarragona;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.20
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;15,784
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;15,275
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;14,935
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.78
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.62
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;9,884
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;9,594
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;9,392
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.07
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.02
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,900
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;5,681
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;5,543
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.29
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.95
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;16,178
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;15,795
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
43 Tarragona;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.63
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;10,094
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;9,856
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
43 Tarragona;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.64
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;6,084
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;5,939
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
43 Tarragona;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.62
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;8,878
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;8,297
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;7,993
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.46
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.03
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,685
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;5,333
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;5,147
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.81
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.54
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,193
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2,964
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2,846
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.83
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.13
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;9,905
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;9,538
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
43 Tarragona;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.29
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;6,364
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;6,136
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
43 Tarragona;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.42
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,541
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;3,402
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
43 Tarragona;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.07
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
43 Tarragona;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;8,685
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;8,317
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;8,087
44 Teruel;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.76
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.11
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,430
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;5,200
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;5,069
44 Teruel;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.76
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.35
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,255
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;3,117
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;3,018
44 Teruel;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.76
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.72
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;8,632
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;8,376
44 Teruel;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
44 Teruel;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.03
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,385
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;5,240
44 Teruel;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
44 Teruel;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.31
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,247
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;3,136
44 Teruel;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
44 Teruel;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.58
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;546
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;493
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;473
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90.29
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86.63
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;359
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;327
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;314
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.09
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87.47
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;187
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;166
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;159
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;88.77
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85.03
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;491
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;466
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
44 Teruel;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94.91
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;332
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;314
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
44 Teruel;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.58
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;159
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;152
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
44 Teruel;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.60
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,466
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;1,399
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;1,359
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.43
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.70
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;860
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;817
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;793
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.00
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.21
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;606
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;582
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;566
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.04
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.40
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,377
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;1,332
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
44 Teruel;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.73
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;798
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;773
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
44 Teruel;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.87
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;579
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;559
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
44 Teruel;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.55
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,328
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;2,254
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;2,206
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.82
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.76
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,456
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;1,411
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;1,383
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.91
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.99
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;872
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;843
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;823
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.67
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.38
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,242
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;2,186
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
44 Teruel;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.50
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,394
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;1,362
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
44 Teruel;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.70
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;848
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;824
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
44 Teruel;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.17
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,738
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;2,662
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;2,615
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.22
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.51
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,727
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;1,682
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;1,658
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.39
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.00
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,011
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;980
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;957
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.93
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.66
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,725
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;2,675
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
44 Teruel;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.17
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,700
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;1,676
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
44 Teruel;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.59
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,025
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;999
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
44 Teruel;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.46
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,607
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;1,509
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;1,434
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.90
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.23
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,028
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;963
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;921
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.68
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;89.59
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;579
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;546
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;513
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.30
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88.60
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,797
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;1,717
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
44 Teruel;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.55
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,161
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;1,115
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
44 Teruel;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.04
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;636
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;602
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
44 Teruel;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.65
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
44 Teruel;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;45,537
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;43,631
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;42,321
45 Toledo;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.81
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.94
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;29,950
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;28,775
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;28,046
45 Toledo;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.08
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.64
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;15,587
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;14,856
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;14,275
45 Toledo;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.31
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.58
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;45,699
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;44,202
45 Toledo;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
45 Toledo;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.72
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;30,007
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;29,178
45 Toledo;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
45 Toledo;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.24
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;15,692
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;15,024
45 Toledo;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
45 Toledo;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.74
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,107
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;2,857
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;2,695
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;91.95
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;86.74
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,075
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;1,905
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;1,815
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;91.81
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;87.47
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,032
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;952
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;880
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.25
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85.27
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,878
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;2,697
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
45 Toledo;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.71
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,943
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;1,835
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
45 Toledo;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.44
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;935
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;862
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
45 Toledo;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.19
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,171
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;6,836
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;6,592
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.33
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.93
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,366
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;4,169
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4,040
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.49
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.53
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,805
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;2,667
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;2,552
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.08
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.98
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,885
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;6,605
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
45 Toledo;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.93
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,181
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4,042
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
45 Toledo;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.68
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,704
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;2,563
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
45 Toledo;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.79
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;13,409
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;12,945
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;12,585
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.54
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.85
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;8,845
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;8,574
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;8,383
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.94
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.78
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,564
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;4,371
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;4,202
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.77
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.07
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;12,932
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;12,532
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
45 Toledo;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.91
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;8,458
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;8,251
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
45 Toledo;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.55
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,474
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;4,281
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
45 Toledo;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.69
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;14,032
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;13,624
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;13,348
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.09
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.13
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;9,306
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;9,064
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;8,909
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.40
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.73
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;4,726
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;4,560
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;4,439
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.49
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.93
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;14,312
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;13,987
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
45 Toledo;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.73
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;9,502
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;9,315
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
45 Toledo;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.03
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,810
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;4,672
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
45 Toledo;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.13
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,818
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;7,369
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;7,101
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.26
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.83
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,358
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;5,063
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;4,899
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.49
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.43
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,460
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;2,306
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;2,202
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.74
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.51
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;8,692
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;8,381
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
45 Toledo;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.42
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;5,923
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;5,735
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
45 Toledo;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.83
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,769
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2,646
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
45 Toledo;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.56
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
45 Toledo;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;188,542
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;179,136
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;173,309
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.01
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.92
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;116,950
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;111,457
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;108,241
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.30
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.55
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;71,592
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;67,679
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;65,068
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.53
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.89
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;189,596
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;182,857
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.45
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;117,660
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;113,919
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.82
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;71,936
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;68,938
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.83
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;14,816
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;13,392
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;12,605
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90.39
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85.08
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;9,137
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;8,286
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;7,842
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.69
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85.83
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;5,679
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;5,106
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;4,763
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89.91
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;83.87
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;13,380
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;12,496
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.39
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;8,401
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;7,885
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.86
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,979
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;4,611
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.61
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;34,444
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;32,324
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;30,967
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.85
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.91
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;20,039
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;18,869
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;18,135
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.16
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.50
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;14,405
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;13,455
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;12,832
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.41
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.08
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;33,477
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;31,919
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;95.35
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;19,455
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;18,623
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.72
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;14,022
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;13,296
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.82
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;54,991
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;52,722
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;51,221
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.87
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.14
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;33,947
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;32,652
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;31,874
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.19
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.89
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;21,044
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;20,070
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;19,347
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.37
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.94
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;53,736
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;52,003
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.77
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;32,946
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;32,036
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.24
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;20,790
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;19,967
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.04
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;55,667
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;53,869
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;52,711
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.77
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.69
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;35,369
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;34,305
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;33,666
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.99
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.19
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;20,298
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;19,564
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;19,045
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.38
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.83
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;56,961
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;55,602
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.61
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;36,185
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;35,435
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.93
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;20,776
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;20,167
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.07
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;28,624
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;26,829
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;25,805
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.73
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.15
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;18,458
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;17,345
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;16,724
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.97
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.61
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;10,166
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;9,484
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;9,081
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.29
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.33
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;32,042
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;30,837
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.24
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;20,673
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;19,940
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.45
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;11,369
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;10,897
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
46 Valencia/València;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.85
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
46 Valencia/València;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;29,786
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;28,499
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;27,699
47 Valladolid;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.68
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.99
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;18,711
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;17,925
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;17,487
47 Valladolid;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.80
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.46
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;11,075
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;10,574
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;10,212
47 Valladolid;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.48
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.21
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;29,528
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;28,624
47 Valladolid;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
47 Valladolid;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.94
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;18,522
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;18,020
47 Valladolid;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
47 Valladolid;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.29
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;11,006
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;10,604
47 Valladolid;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
47 Valladolid;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.35
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,723
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;1,558
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;1,480
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;90.42
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;85.90
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,075
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;971
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;925
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.33
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;86.05
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;648
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;587
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;555
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90.59
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;85.65
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,544
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;1,435
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
47 Valladolid;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;92.94
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;969
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;903
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
47 Valladolid;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;93.19
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;575
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;532
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
47 Valladolid;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.52
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,090
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;3,857
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;3,720
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.30
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.95
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,363
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;2,220
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;2,144
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.95
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.73
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,727
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;1,637
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;1,576
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.79
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.26
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,840
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;3,697
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
47 Valladolid;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.28
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,216
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;2,133
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
47 Valladolid;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.25
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,624
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;1,564
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
47 Valladolid;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.31
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;7,937
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;7,644
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;7,464
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.31
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.04
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,902
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;4,731
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;4,648
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.51
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.82
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,035
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;2,913
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;2,816
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.98
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.78
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;7,521
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;7,323
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
47 Valladolid;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.37
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,584
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;4,488
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
47 Valladolid;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.91
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,937
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;2,835
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
47 Valladolid;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.53
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;9,844
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;9,614
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;9,417
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.66
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.66
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,249
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;6,128
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;6,030
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;98.06
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.50
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,595
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;3,486
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;3,387
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.97
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.21
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;9,791
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;9,582
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
47 Valladolid;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.87
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;6,258
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;6,150
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
47 Valladolid;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.27
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,533
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;3,432
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
47 Valladolid;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.14
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;6,192
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;5,826
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;5,618
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.09
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.73
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;4,122
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;3,875
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;3,740
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.01
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.73
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;2,070
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;1,951
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;1,878
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.25
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.72
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;6,832
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;6,587
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
47 Valladolid;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.41
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,495
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;4,346
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
47 Valladolid;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.69
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;2,337
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;2,241
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
47 Valladolid;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.89
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
47 Valladolid;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;11,129
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;10,722
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;10,476
49 Zamora;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.34
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.13
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;7,142
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;6,881
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;6,753
49 Zamora;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.35
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.55
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,987
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;3,841
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;3,723
49 Zamora;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.34
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.38
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;11,085
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;10,808
49 Zamora;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
49 Zamora;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.50
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;7,090
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;6,947
49 Zamora;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
49 Zamora;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.98
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,995
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;3,861
49 Zamora;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
49 Zamora;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.65
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;658
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;607
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;579
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;92.25
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;87.99
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;454
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;422
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;403
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;92.95
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;88.77
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;204
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;185
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;176
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;90.69
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;86.27
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;609
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;573
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
49 Zamora;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94.09
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;416
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;394
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
49 Zamora;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.71
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;193
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;179
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
49 Zamora;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.75
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,590
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;1,513
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;1,476
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.16
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.83
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;971
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;926
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;904
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.37
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.10
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;619
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;587
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;572
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.83
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.41
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,467
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;1,430
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
49 Zamora;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.48
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;904
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;880
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
49 Zamora;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.35
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;563
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;550
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
49 Zamora;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.69
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,885
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;2,805
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;2,745
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.23
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.15
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,814
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;1,763
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;1,745
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.19
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;96.20
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,071
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;1,042
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;1,000
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.29
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.37
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,724
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;2,657
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
49 Zamora;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.54
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,697
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;1,678
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
49 Zamora;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.88
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,027
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;979
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
49 Zamora;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.33
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,519
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;3,444
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;3,391
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.87
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;96.36
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,237
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;2,199
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;2,175
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;98.30
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;97.23
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,282
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;1,245
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;1,216
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.11
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.85
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,525
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;3,468
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
49 Zamora;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.38
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,261
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;2,233
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
49 Zamora;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.76
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,264
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;1,235
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
49 Zamora;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.71
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;2,477
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;2,353
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;2,285
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.99
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.25
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,666
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;1,571
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;1,526
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.30
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.60
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;811
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;782
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;759
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.42
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.59
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;2,760
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;2,680
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
49 Zamora;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.10
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,812
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;1,762
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
49 Zamora;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.24
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;948
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;918
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
49 Zamora;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.84
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
49 Zamora;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;57,027
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;54,313
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;52,757
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.24
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.51
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;35,586
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;33,959
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;33,089
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.43
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.98
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;21,441
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;20,354
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;19,668
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.93
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.73
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;56,550
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;54,788
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.88
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;35,287
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;34,293
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.18
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;21,263
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;20,495
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.39
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,934
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;3,531
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;3,340
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;89.76
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;84.90
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;2,537
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;2,283
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;2,173
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;89.99
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;85.65
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,397
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;1,248
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;1,167
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;89.33
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;83.54
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,478
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;3,247
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;93.36
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;2,247
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;2,114
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.08
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,231
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;1,133
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;92.04
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;8,896
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;8,411
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;8,114
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.55
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.21
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;5,192
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;4,930
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;4,765
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.95
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;91.78
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,704
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;3,481
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;3,349
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;93.98
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.42
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;8,456
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;8,153
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.42
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;4,966
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;4,796
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.58
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;3,490
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;3,357
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.19
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;15,641
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;15,038
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;14,690
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.14
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.92
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;9,641
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;9,292
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;9,105
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.38
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.44
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;6,000
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;5,746
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;5,585
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.77
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.08
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;14,794
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;14,399
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.33
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;9,065
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;8,843
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.55
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;5,729
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;5,556
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.98
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;18,115
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;17,594
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;17,236
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.12
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;95.15
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;11,469
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;11,146
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;10,949
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;97.18
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;95.47
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;6,646
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;6,448
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;6,287
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;97.02
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.60
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;18,324
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;17,918
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.78
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;11,575
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;11,350
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.06
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;6,749
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;6,568
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.32
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;10,441
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;9,739
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;9,377
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.28
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;89.81
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;6,747
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;6,308
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;6,097
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.49
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.37
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;3,694
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;3,431
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;3,280
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.88
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;88.79
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;11,498
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;11,071
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.29
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;7,434
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;7,190
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.72
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;4,064
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;3,881
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
50 Zaragoza;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.50
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
50 Zaragoza;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;3,091
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;2,942
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;2,860
51 Ceuta;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.18
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;92.53
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;1,976
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;1,880
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;1,834
51 Ceuta;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.14
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.81
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,115
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;1,062
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;1,026
51 Ceuta;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.25
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.02
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;3,046
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;2,955
51 Ceuta;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
51 Ceuta;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.01
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;1,952
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;1,901
51 Ceuta;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
51 Ceuta;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.39
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,094
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;1,054
51 Ceuta;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
51 Ceuta;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.34
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;268
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;239
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;220
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;89.18
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;82.09
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;186
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;163
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;151
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;87.63
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;81.18
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;82
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;76
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;69
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;92.68
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;84.15
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;211
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;193
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
51 Ceuta;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;91.47
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;152
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;140
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
51 Ceuta;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;92.11
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;59
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;53
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
51 Ceuta;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;89.83
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;596
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;563
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;537
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.46
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.10
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;339
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;320
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;306
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;94.40
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.27
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;257
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;243
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;231
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.55
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.88
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;565
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;536
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
51 Ceuta;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94.87
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;318
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;302
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
51 Ceuta;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;94.97
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;247
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;234
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
51 Ceuta;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.74
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;804
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;773
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;757
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.14
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.15
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;509
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;491
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;480
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.46
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.30
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;295
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;282
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;277
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.59
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;93.90
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;788
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;770
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
51 Ceuta;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.72
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;504
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;492
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
51 Ceuta;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.62
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;284
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;278
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
51 Ceuta;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.89
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;827
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;807
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;799
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;97.58
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;96.61
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;546
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;536
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;531
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;98.17
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;97.25
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;281
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;271
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;268
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.44
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;95.37
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;845
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;833
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
51 Ceuta;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;98.58
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;557
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;550
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
51 Ceuta;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.74
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;288
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;283
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
51 Ceuta;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;98.26
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;596
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;560
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;547
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;93.96
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.78
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;396
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;370
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;366
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.43
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.42
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;200
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;190
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;181
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.00
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;90.50
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;637
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;623
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
51 Ceuta;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.80
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;421
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;417
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
51 Ceuta;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;99.05
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;216
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;206
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
51 Ceuta;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.37
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
51 Ceuta;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;4,263
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the first trimester;2026QI;4,048
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2026QII;3,907
52 Melilla;All ages;Cohort January 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.96
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;91.65
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;3,039
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the first trimester;2026QI;2,895
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2026QII;2,808
52 Melilla;All ages;Cohort January 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.26
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.40
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;1,224
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the first trimester;2026QI;1,153
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2026QII;1,099
52 Melilla;All ages;Cohort January 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;94.20
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.79
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;4,252
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2026QII;4,087
52 Melilla;All ages;Cohort April 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
52 Melilla;All ages;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.12
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;3,032
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2026QII;2,930
52 Melilla;All ages;Cohort April 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
52 Melilla;All ages;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.64
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;1,220
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2026QII;1,157
52 Melilla;All ages;Cohort April 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
52 Melilla;All ages;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;94.84
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;All ages;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;407
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the first trimester;2026QI;361
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QII;331
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;88.70
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;81.33
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;255
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the first trimester;2026QI;232
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QII;215
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;90.98
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;84.31
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;152
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the first trimester;2026QI;129
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QII;116
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;84.87
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;76.32
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;362
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QII;329
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
52 Melilla;Less than 30 years;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;90.88
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;239
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QII;220
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
52 Melilla;Less than 30 years;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;92.05
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;123
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QII;109
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
52 Melilla;Less than 30 years;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;88.62
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;Less than 30 years;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;849
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the first trimester;2026QI;801
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QII;766
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;94.35
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;90.22
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;548
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the first trimester;2026QI;514
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QII;497
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;93.80
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;90.69
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;301
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the first trimester;2026QI;287
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QII;269
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.35
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;89.37
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;816
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QII;771
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
52 Melilla;From 30 to 39;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;94.49
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;516
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QII;492
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
52 Melilla;From 30 to 39;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;95.35
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;300
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QII;279
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
52 Melilla;From 30 to 39;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;93.00
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 30 to 39;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,202
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the first trimester;2026QI;1,151
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QII;1,118
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;95.76
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.01
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;866
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the first trimester;2026QI;830
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QII;809
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;95.84
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;93.42
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;336
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the first trimester;2026QI;321
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QII;309
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.54
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;91.96
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,185
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QII;1,148
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
52 Melilla;From 40 to 49;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.88
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;835
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QII;813
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
52 Melilla;From 40 to 49;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;97.37
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;350
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QII;335
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
52 Melilla;From 40 to 49;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;95.71
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 40 to 49;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;1,062
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the first trimester;2026QI;1,021
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QII;1,001
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.14
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;94.26
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;794
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the first trimester;2026QI;766
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QII;753
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.47
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;94.84
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;268
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the first trimester;2026QI;255
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QII;248
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;95.15
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;92.54
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;1,062
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QII;1,038
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
52 Melilla;From 50 to 59;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;97.74
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;802
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QII;787
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
52 Melilla;From 50 to 59;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;98.13
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;260
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QII;251
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
52 Melilla;From 50 to 59;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;96.54
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;From 50 to 59;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;743
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the first trimester;2026QI;714
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QII;691
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Number at the start of the quarter;2026QI;100.00
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the first trimester;2026QI;96.10
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QII;93.00
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;576
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the first trimester;2026QI;553
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QII;534
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Number at the start of the quarter;2026QI;100.00
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the first trimester;2026QI;96.01
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QII;92.71
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;167
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the first trimester;2026QI;161
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QII;157
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Number at the start of the quarter;2026QI;100.00
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the first trimester;2026QI;96.41
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QII;94.01
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort January 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;827
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QII;801
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QII;100.00
52 Melilla;60 years old and over;Cohort April 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QII;96.86
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;640
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QII;618
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QII;100.00
52 Melilla;60 years old and over;Cohort April 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QII;96.56
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;187
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QII;183
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QII;100.00
52 Melilla;60 years old and over;Cohort April 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QII;97.86
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort April 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort July 1;Females;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Total;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Males;Percentage of survivals in the fourth semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the second trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Survival in the third trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Number at the start of the quarter;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the first trimester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the second semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the third semester;2026QI;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QII;""
52 Melilla;60 years old and over;Cohort October 1;Females;Percentage of survivals in the fourth semester;2026QI;""